Mutation	O
of	O
tyrosines	O
492/493	O
in	O
the	O
kinase	B-protein
domain	I-protein
of	O
ZAP-70	B-protein
affects	O
multiple	O
T-cell	B-protein
receptor	I-protein
signaling	O
pathways	O
.	O

The	O
protein-tyrosine	B-protein
kinase	I-protein
ZAP-70	B-protein
is	O
implicated	O
,	O
together	O
with	O
the	O
Src	B-protein
kinase	I-protein
p56	B-protein
(	I-protein
lck	I-protein
)	I-protein
,	O
in	O
controlling	O
the	O
early	O
steps	O
of	O
the	O
T-cell	O
antigen	O
receptor	O
(	O
TCR	B-protein
)	O
signaling	O
cascade	O
.	O

To	O
help	O
elucidate	O
further	O
the	O
mechanism	O
by	O
which	O
ZAP-70	B-protein
regulates	O
these	O
initial	O
events	O
,	O
we	O
used	O
a	O
dominant-negative	O
mutant	O
approach	O
.	O

We	O
overexpressed	O
in	O
the	O
Jurkat	B-cell_line
T-cell	I-cell_line
line	I-cell_line
ZAP-70	B-protein
mutated	O
on	O
Tyr-492	O
and	O
Tyr-493	O
in	O
the	O
putative	O
regulatory	O
loop	O
of	O
its	O
kinase	B-protein
domain	I-protein
.	O

This	O
mutant	O
inhibited	O
TCR	B-protein
-induced	O
activation	O
of	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
by	O
interfering	O
with	O
both	O
intracellular	O
calcium	O
increase	O
and	O
Ras	B-protein
-regulated	O
activation	O
of	O
extracellular	B-protein
signal-regulated	I-protein
kinases	I-protein
.	O

Moreover	O
,	O
TCR	B-protein
-induced	O
phosphorylation	O
of	O
pp36-38	B-protein
,	O
thought	O
to	O
play	O
a	O
role	O
upstream	O
of	O
these	O
pathways	O
,	O
was	O
found	O
to	O
be	O
reduced	O
.	O

In	O
contrast	O
,	O
overexpression	O
of	O
wild-type	B-protein
ZAP-70	I-protein
induced	O
constitutive	O
activation	O
of	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
.	O

The	O
ZAP-70	B-protein
mutant	O
studied	O
here	O
could	O
be	O
phosphorylated	O
on	O
tyrosine	O
when	O
associated	O
to	O
the	O
TCR	B-protein
zeta	I-protein
chain	I-protein
and	O
was	O
able	O
to	O
bind	O
p56	B-protein
(	I-protein
lck	I-protein
)	I-protein
.	O

This	O
result	O
demonstrates	O
that	O
Tyr-492	O
and	O
Tyr-493	O
are	O
not	O
responsible	O
for	O
the	O
Src	O
homology	O
domain	O
2-mediated	O
association	O
of	O
p56	B-protein
(	I-protein
lck	I-protein
)	I-protein
with	O
ZAP-70	B-protein
.	O

Our	O
data	O
are	O
most	O
consistent	O
with	O
a	O
model	O
in	O
which	O
recruitment	O
to	O
the	O
TCR	B-protein
allows	O
ZAP-70	B-protein
autophosphorylation	O
and	O
binding	O
to	O
p56	B-protein
(	I-protein
lck	I-protein
)	I-protein
,	O
which	O
in	O
turn	O
phosphorylates	O
Tyr-492	O
and/or	O
Tyr-493	O
with	O
consequent	O
up-regulation	O
of	O
the	O
ZAP-70	B-protein
kinase	O
activity	O
.	O

ZAP-70	B-protein
will	O
then	O
be	O
able	O
to	O
effectively	O
control	O
phosphorylation	O
of	O
its	O
substrates	O
and	O
lead	O
to	O
gene	O
activation	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

51	NULL
,	NULL
Issue	NULL
of	NULL
December	NULL
20	NULL
,	NULL
pp	NULL
.	NULL

32644-32652	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Mutation	NULL
of	NULL
Tyrosines	NULL
492/493	NULL
in	NULL
the	NULL
Kinase	NULL
Domain	NULL
of	NULL
ZAP-70	NULL
Affects	NULL
Multiple	NULL
T-cell	NULL
Receptor	NULL
Signaling	NULL
Pathways*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
26	NULL
,	NULL
1996	NULL
)	NULL
Dominique	NULL
Mége	NULL
,	NULL
Vincenzo	NULL
Di	NULL
Valérie	NULL
Germain	NULL
,	NULL
Loretta	NULL
Tuosto§	NULL
,	NULL
Fredérique	NULL
Michel	NULL
,	NULL
and	NULL
Oreste	NULL
Acuto1	NULL
From	NULL
the	NULL
Molecular	NULL
Immunology	NULL
Unit	NULL
,	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Pasteur	NULL
Institute	NULL
25	NULL
,	NULL
rue	NULL
du	NULL
Dr.	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
,	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
The	NULL
protein-tyrosine	NULL
kinase	NULL
ZAP-70	NULL
is	NULL
implicated	NULL
,	NULL
together	NULL
with	NULL
the	NULL
Sre	NULL
kinase	NULL
p56'**	NULL
,	NULL
in	NULL
controlling	NULL
the	NULL
early	NULL
steps	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
signaling	NULL
cascade	NULL
.	NULL

To	NULL
help	NULL
elucidate	NULL
further	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
ZAP-70	NULL
regulates	NULL
these	NULL
initial	NULL
events	NULL
,	NULL
we	NULL
used	NULL
a	NULL
dominant-negative	NULL
mutant	NULL
approach	NULL
.	NULL

We	NULL
overexpressed	NULL
in	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
ZAP-70	NULL
mutated	NULL
on	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
in	NULL
the	NULL
putative	NULL
regulatory	NULL
loop	NULL
of	NULL
its	NULL
kinase	NULL
domain	NULL
.	NULL

This	NULL
mutant	NULL
inhibited	NULL
TCR-induced	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
by	NULL
interfering	NULL
with	NULL
both	NULL
intracellular	NULL
calcium	NULL
increase	NULL
and	NULL
Ras-regulated	NULL
activation	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
.	NULL

Moreover	NULL
,	NULL
TCR-induced	NULL
phosphorylation	NULL
of	NULL
pp36-38	NULL
,	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
role	NULL
upstream	NULL
of	NULL
these	NULL
pathways	NULL
,	NULL
was	NULL
found	NULL
to	NULL
be	NULL
reduced	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
overexpression	NULL
of	NULL
wild-type	NULL
ZAP-70	NULL
induced	NULL
constitutive	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
ZAP-70	NULL
mutant	NULL
studied	NULL
here	NULL
could	NULL
be	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
when	NULL
associated	NULL
to	NULL
the	NULL
TCR	NULL
{	NULL
chain	NULL
and	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
p56	NULL
``	NULL
.	NULL

This	NULL
result	NULL
demonstrates	NULL
that	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
are	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
Sre	NULL
homology	NULL
domain	NULL
2-mediated	NULL
association	NULL
of	NULL
p56	NULL
``	NULL
with	NULL
ZAP-70	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
most	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
recruitment	NULL
to	NULL
the	NULL
TCR	NULL
allows	NULL
ZAP-70	NULL
autophosphorylation	NULL
and	NULL
binding	NULL
to	NULL
p56	NULL
``	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
phosphorylates	NULL
Tyr-492	NULL
and/or	NULL
Tyr-493	NULL
with	NULL
consequent	NULL
up-regulation	NULL
of	NULL
the	NULL
ZAP-70	NULL
kinase	NULL
activity	NULL
.	NULL

ZAP-70	NULL
will	NULL
then	NULL
be	NULL
able	NULL
to	NULL
effectively	NULL
control	NULL
phosphorylation	NULL
of	NULL
its	NULL
substrates	NULL
and	NULL
lead	NULL
to	NULL
gene	NULL
activation	NULL
.	NULL

Biochemical	NULL
and	NULL
genetic	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
cytoplasmic	NULL
protein-tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
'	NULL
of	NULL
the	NULL
Src	NULL
and	NULL
Syk	NULL
families	NULL
control	NULL
the	NULL
early	NULL
steps	NULL
of	NULL
the	NULL
signaling	NULL
cascade	NULL
initi-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Pasteur	NULL
Institute	NULL
,	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
the	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
,	NULL
and	NULL
the	NULL
European	NULL
Economic	NULL
Community	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

7	NULL
Supported	NULL
by	NULL
fellowships	NULL
from	NULL
the	NULL
European	NULL
Economic	NULL
Community	NULL
and	NULL
from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
.	NULL

§	NULL
Recipient	NULL
of	NULL
a	NULL
fellowship	NULL
for	NULL
AIDS	NULL
research	NULL
from	NULL
the	NULL
Istituto	NULL
Supe-riore	NULL
di	NULL
Sanita	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

«	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
33-	NULL
(	NULL
1	NULL
)	NULL
4568-8637	NULL
;	NULL
Fax	NULL
:	NULL
33-	NULL
(	NULL
1	NULL
)	NULL
4061-3204	NULL
.	NULL

E-mail	NULL
:	NULL
oacuto	NULL
@	NULL
pasteur.fr	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
PTK	NULL
,	NULL
protein-tyrosine	NULL
kinase	NULL
;	NULL
TCR	NULL
,	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
ITAM	NULL
,	NULL
immunoreceptor	NULL
tyrosine-based	NULL
activation	NULL
motif	NULL
;	NULL
SH2	NULL
,	NULL
Sre	NULL
homology	NULL
domain	NULL
2	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
VSV-G	NULL
,	NULL
vesicular	NULL
stomatitis	NULL
virus	NULL
glycoprotein	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
AU	NULL
,	NULL
arbitrary	NULL
unit	NULL
;	NULL
[	NULL
Ca**1	NULL
;	NULL
,	NULL
concentration	NULL
of	NULL
free	NULL
cytosolic	NULL
calcium	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin-2	NULL
.	NULL

32644	NULL
ated	NULL
by	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
triggering	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
TCR	NULL
signal-transducing	NULL
subunits	NULL
(	NULL
y	NULL
,	NULL
3	NULL
,	NULL
and	NULL
e	NULL
chains	NULL
of	NULL
the	NULL
CD3	NULL
complex	NULL
and	NULL
the	NULL
{	NULL
homodimer	NULL
)	NULL
do	NULL
not	NULL
possess	NULL
intrinsic	NULL
PTK	NULL
activity	NULL
;	NULL
yet	NULL
,	NULL
TCR	NULL
ligation	NULL
by	NULL
antigen/major	NULL
histocompatibility	NULL
complex	NULL
or	NULL
by	NULL
anti-TCR	NULL
mAbs	NULL
induces	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
immunoreceptor	NULL
tyrosine-based	NULL
activation	NULL
motifs	NULL
(	NULL
ITAMs	NULL
)	NULL
present	NULL
in	NULL
their	NULL
cytoplasmic	NULL
tails	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
an	NULL
event	NULL
essential	NULL
for	NULL
activation	NULL
of	NULL
lymphokine	NULL
genes	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
the	NULL
Src	NULL
family	NULL
PTKs	NULL
p56	NULL
``	NULL
**	NULL
and	NULL
p59	NULL
``	NULL
mediate	NULL
phosphorylation	NULL
of	NULL
the	NULL
ITAM	NULL
(	NULL
6-9	NULL
)	NULL
,	NULL
although	NULL
the	NULL
former	NULL
may	NULL
have	NULL
a	NULL
prominent	NULL
role	NULL
(	NULL
10	NULL
)	NULL
.	NULL

ITAM	NULL
phosphorylation	NULL
allows	NULL
recruitment	NULL
of	NULL
the	NULL
Syk-related	NULL
PTK	NULL
ZAP-70	NULL
to	NULL
the	NULL
TCR	NULL
(	NULL
11	NULL
)	NULL
via	NULL
binding	NULL
of	NULL
the	NULL
two	NULL
tandemly	NULL
arranged	NULL
ZAP-70	NULL
SH2	NULL
domains	NULL
to	NULL
the	NULL
two	NULL
phosphotyrosines	NULL
of	NULL
ITAMs	NULL
(	NULL
8	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
ZAP-70	NULL
itself	NULL
is	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
resi-dues	NULL
,	NULL
a	NULL
modification	NULL
contributing	NULL
to	NULL
its	NULL
catalytic	NULL
activation	NULL
(	NULL
14-16	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
ZAP-70	NULL
in	NULL
TCR	NULL
signaling	NULL
has	NULL
been	NULL
established	NULL
by	NULL
studies	NULL
of	NULL
a	NULL
rare	NULL
human	NULL
immunodeficiency	NULL
caused	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
ZAP-70	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

In	NULL
these	NULL
individuals	NULL
,	NULL
only	NULL
CD4*	NULL
T	NULL
cells	NULL
develop	NULL
but	NULL
fail	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
ligation	NULL
and	NULL
show	NULL
a	NULL
largely	NULL
compromised	NULL
activation-in-duced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
intracellular	NULL
proteins	NULL
and	NULL
calcium	NULL
increase	NULL
.	NULL

The	NULL
mechanism	NULL
whereby	NULL
ZAP-70	NULL
,	NULL
once	NULL
recruited	NULL
to	NULL
the	NULL
ITAMs	NULL
,	NULL
becomes	NULL
tyrosine-phosphorylated	NULL
and	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
this	NULL
event	NULL
on	NULL
TCR-controlled	NULL
signaling	NULL
pathways	NULL
remain	NULL
partly	NULL
unclear	NULL
.	NULL

Biochemical	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
within	NULL
the	NULL
kinase	NULL
domain	NULL
of	NULL
ZAP-70	NULL
are	NULL
phosphorylated	NULL
after	NULL
TCR	NULL
stimulation	NULL
(	NULL
15	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Homolo-gous	NULL
tyrosines	NULL
are	NULL
found	NULL
in	NULL
a	NULL
number	NULL
of	NULL
PTKs	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
their	NULL
phosphorylation	NULL
is	NULL
thought	NULL
to	NULL
regulate	NULL
the	NULL
enzymatic	NULL
activity	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Although	NULL
in	NULL
vitro	NULL
ZAP-70	NULL
is	NULL
essentially	NULL
unable	NULL
to	NULL
auto-phosphorylate	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
(	NULL
19	NULL
)	NULL
,	NULL
studies	NULL
in	NULL
heterolo-gous	NULL
cell	NULL
systems	NULL
and	NULL
in	NULL
vitro	NULL
indicated	NULL
that	NULL
p56'**	NULL
efficiently	NULL
phosphorylates	NULL
ZAP-70	NULL
on	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
regulatory	NULL
role	NULL
of	NULL
p56	NULL
``	NULL
**	NULL
on	NULL
ZAP-70	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
mutational	NULL
analysis	NULL
of	NULL
ZAP-70	NULL
suggested	NULL
that	NULL
the	NULL
kinase	NULL
activity	NULL
was	NULL
positively	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
of	NULL
Tyr-493	NULL
,	NULL
whereas	NULL
a	NULL
negative	NULL
regulatory	NULL
function	NULL
was	NULL
proposed	NULL
for	NULL
Tyr-492	NULL
.	NULL

Consistently	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
a	NULL
ZAP-70	NULL
Y493F	NULL
mutant	NULL
failed	NULL
to	NULL
complement	NULL
,	NULL
whereas	NULL
a	NULL
Y492F	NULL
mutant	NULL
enhanced	NULL
BCR-stimulated	NULL
IL-2	NULL
gene	NULL
promoter	NULL
activity	NULL
in	NULL
a	NULL
Syk-null	NULL
chicken	NULL
B-cell	NULL
line	NULL
(	NULL
15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
double	NULL
mutant	NULL
Y492F/Y493F	NULL
was	NULL
ineffective	NULL
in	NULL
activating	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

We	NULL
have	NULL
reported	NULL
previously	NULL
that	NULL
after	NULL
TCR	NULL
triggering	NULL
,	NULL
p56	NULL
``	NULL
associates	NULL
via	NULL
its	NULL
SH2	NULL
domain	NULL
to	NULL
tyrosine-phosphorylated	NULL
ZAP-70	NULL
bound	NULL
to	NULL
&	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
and	NULL
proposed	NULL
that	NULL
p56	NULL
``	NULL
**	NULL
recruitment	NULL
may	NULL
be	NULL
important	NULL
for	NULL
regulating	NULL
ZAP-70	NULL
activity	NULL
and/or	NULL
for	NULL
phosphorylating	NULL
other	NULL
substrates	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
binding	NULL
of	NULL
ZAP-70	NULL
to	NULL
phosphorylated	NULL
£	NULL
chain	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Src	NULL
kinases	NULL
,	NULL
resulted	NULL
in	NULL
enhanced	NULL
ZAP-70	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
ZAP-70	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Activation	NULL
autophosphorylation	NULL
(	NULL
24	NULL
)	NULL
.	NULL

ZAP-70	NULL
autophosphorylated	NULL
under	NULL
those	NULL
conditions	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
SH2	NULL
domains	NULL
of	NULL
Abl	NULL
and	NULL
ras-GAP	NULL
,	NULL
and	NULL
an	NULL
association	NULL
in	NULL
Jurkat	NULL
cells	NULL
with	NULL
these	NULL
proteins	NULL
was	NULL
detected	NULL
after	NULL
TCR	NULL
activation	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
showed	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
ZAP-70	NULL
is	NULL
also	NULL
important	NULL
for	NULL
recruiting	NULL
signaling	NULL
proteins	NULL
to	NULL
the	NULL
activated	NULL
TCR	NULL
,	NULL
although	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
these	NULL
associations	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

In	NULL
this	NULL
work	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
further	NULL
understand	NULL
the	NULL
regulation	NULL
of	NULL
ZAP-70	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
following	NULL
TCR	NULL
stimulation	NULL
and	NULL
the	NULL
consequences	NULL
of	NULL
these	NULL
modifications	NULL
on	NULL
the	NULL
ensuing	NULL
signaling	NULL
cascade	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
analyzed	NULL
in	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
the	NULL
effect	NULL
of	NULL
overexpressing	NULL
ZAP-70	NULL
mutated	NULL
on	NULL
both	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
on	NULL
early	NULL
TCR	NULL
signaling	NULL
events	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
.	NULL

This	NULL
study	NULL
provided	NULL
additional	NULL
clues	NULL
on	NULL
the	NULL
mechanistic	NULL
basis	NULL
for	NULL
ZAP-70	NULL
implication	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Lines	NULL
and	NULL
Antibodies-The	NULL
human	NULL
leukemia	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
cal	NULL
serum	NULL
,	NULL
L-glutamine	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
following	NULL
mouse	NULL
mAbs	NULL
were	NULL
used	NULL
:	NULL
101.5.2	NULL
(	NULL
anti-human	NULL
TCR	NULL
V	NULL
B8	NULL
,	NULL
IgM	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
E.	NULL
L.	NULL
Reinherz	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bos-ton	NULL
,	NULL
MA	NULL
)	NULL
;	NULL
4G10	NULL
,	NULL
(	NULL
anti-phosphotyrosine	NULL
IgGZb	NULL
(	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antibodies	NULL
were	NULL
:	NULL
anti-human	NULL
p56**	NULL
C-term	NULL
(	NULL
2102	NULL
)	NULL
,	NULL
anti-Grb2	NULL
(	NULL
C-28	NULL
)	NULL
,	NULL
anti-ERK	NULL
(	NULL
K-23	NULL
)	NULL
(	NULL
all	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
anti-	NULL
{	NULL
chain	NULL
,	NULL
raised	NULL
against	NULL
the	NULL
entire	NULL
recombinant	NULL
protein	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
J.	NULL
Ravetch	NULL
,	NULL
Memorial	NULL
Sloan-Kettering	NULL
Institute	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
;	NULL
anti-ZAP-70	NULL
antiserum	NULL
(	NULL
4.06	NULL
)	NULL
directed	NULL
against	NULL
a	NULL
synthetic	NULL
peptide	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
106-117	NULL
of	NULL
the	NULL
human	NULL
sequence	NULL
was	NULL
produced	NULL
in	NULL
our	NULL
laboratory	NULL
using	NULL
keyhole	NULL
limpet	NULL
hemocyanin	NULL
as	NULL
a	NULL
carrier	NULL
;	NULL
anti-VSV-G	NULL
epitope	NULL
antiserum	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Arpin	NULL
,	NULL
Institut	NULL
Curie	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
was	NULL
raised	NULL
against	NULL
an	NULL
11-amino	NULL
acid	NULL
determinant	NULL
derived	NULL
from	NULL
a	NULL
vesicular	NULL
stomatitis	NULL
virus	NULL
glycoprotein	NULL
(	NULL
VSV-G	NULL
)	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Plasmids	NULL
and	NULL
Constructs-NFAT-luciferase	NULL
reporter	NULL
construct	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
C.	NULL
Baldari	NULL
,	NULL
University	NULL
of	NULL
Siena	NULL
,	NULL
Siena	NULL
,	NULL
Italy	NULL
)	NULL
,	NULL
derived	NULL
from	NULL
pUBT-luc	NULL
plasmid	NULL
(	NULL
26	NULL
)	NULL
,	NULL
contained	NULL
the	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
binding	NULL
site	NULL
(	NULL
27	NULL
)	NULL
.	NULL

pSV-fBgal	NULL
vector	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
contained	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
SV40	NULL
promoter/enhancer	NULL
.	NULL

The	NULL
full-length	NULL
EcoRI	NULL
fragment	NULL
encoding	NULL
the	NULL
human	NULL
ZAP-70	NULL
cDNA	NULL
(	NULL
11	NULL
)	NULL
in	NULL
pBluescript	NULL
(	NULL
pBS	NULL
)	NULL
vector	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
A.	NULL
Weiss	NULL
(	NULL
University	NULL
of	NULL
California	NULL
at	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
VSV-G-pBS	NULL
plasmid	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Arpin	NULL
)	NULL
contained	NULL
the	NULL
sequence	NULL
coding	NULL
for	NULL
the	NULL
epitope	NULL
tag	NULL
derived	NULL
from	NULL
VSV-G	NULL
.	NULL

The	NULL
VSV-G	NULL
tag	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
ZAP-70	NULL
was	NULL
added	NULL
by	NULL
PCR	NULL
.	NULL

A	NULL
3	NULL
'	NULL
primer	NULL
,	NULL
which	NULL
introduced	NULL
a	NULL
PspAlI	NULL
cloning	NULL
site	NULL
instead	NULL
of	NULL
the	NULL
stop	NULL
codon	NULL
,	NULL
combined	NULL
with	NULL
5	NULL
primer	NULL
encompassing	NULL
the	NULL
Nsil	NULL
unique	NULL
site	NULL
(	NULL
position	NULL
1734	NULL
)	NULL
generated	NULL
a	NULL
350-bp	NULL
Nsil-PspAl	NULL
PCR	NULL
fragment	NULL
that	NULL
was	NULL
ligated	NULL
together	NULL
with	NULL
the	NULL
EcoRI-Nsil	NULL
ZAP-70	NULL
cDNA	NULL
fragment	NULL
(	NULL
1-1734	NULL
)	NULL
to	NULL
VSV-G-pBS	NULL
vector	NULL
restricted	NULL
with	NULL
EcoRI	NULL
and	NULL
PspAl	NULL
.	NULL

The	NULL
resulting	NULL
ZAP-70-VSV-G	NULL
comprised	NULL
the	NULL
entire	NULL
619	NULL
residues	NULL
of	NULL
ZAP-70	NULL
followed	NULL
by	NULL
a	NULL
7-amino	NULL
acid	NULL
``	NULL
spacer	NULL
``	NULL
(	NULL
REGPPGP	NULL
)	NULL
and	NULL
by	NULL
the	NULL
11-amino	NULL
acid	NULL
epitope	NULL
tag	NULL
(	NULL
YTDIEMNRLGK	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
first	NULL
208	NULL
bp	NULL
of	NULL
the	NULL
5	NULL
``	NULL
untranslated	NULL
region	NULL
of	NULL
ZAP-70	NULL
cDNA	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
a	NULL
5	NULL
'	NULL
Pst	NULL
]	NULL
cloning	NULL
site	NULL
was	NULL
introduced	NULL
.	NULL

A	NULL
5	NULL
'	NULL
primer	NULL
containing	NULL
a	NULL
Psfl	NULL
site	NULL
at	NULL
nucleotide	NULL
position	NULL
198	NULL
and	NULL
a	NULL
3	NULL
'	NULL
primer	NULL
lying	NULL
downstream	NULL
of	NULL
the	NULL
XhoI	NULL
unique	NULL
site	NULL
(	NULL
position	NULL
530	NULL
)	NULL
allowed	NULL
us	NULL
to	NULL
isolate	NULL
a	NULL
PsfI-Xhol	NULL
888-bp	NULL
PCR	NULL
fragment	NULL
that	NULL
was	NULL
ligated	NULL
together	NULL
with	NULL
a	NULL
1.6-kb	NULL
Xhol-Bg/lI	NULL
fragment	NULL
from	NULL
the	NULL
ZAP-70-VSV-G	NULL
construct	NULL
and	NULL
a	NULL
pBS-KS	NULL
vector	NULL
digested	NULL
with	NULL
Pstl	NULL
and	NULL
BamHI	NULL
.	NULL

The	NULL
1951-bp	NULL
ZAP-70-VSV-G	NULL
construct	NULL
(	NULL
ZAP-ZOWT	NULL
)	NULL
was	NULL
excised	NULL
with	NULL
Eco	NULL
RI	NULL
and	NULL
Xbal	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
pSRapuro	NULL
vector	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
R.	NULL
Sekaly	NULL
,	NULL
Institut	NULL
de	NULL
Recherches	NULL
Cliniques	NULL
de	NULL
Montreal	NULL
,	NULL
Montreal	NULL
,	NULL
Canada	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
the	NULL
pSRa296	NULL
mammalian	NULL
vector	NULL
(	NULL
28	NULL
)	NULL
and	NULL
conferred	NULL
the	NULL
resistance	NULL
to	NULL
puromycin	NULL
.	NULL

Kinase	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
three	NULL
PCR	NULL
reactions	NULL
using	NULL
for	NULL
the	NULL
third	NULL
reaction	NULL
the	NULL
same	NULL
couple	NULL
of	NULL
external	NULL
primers	NULL
,	NULL
because	NULL
both	NULL
mutations	NULL
were	NULL
targeted	NULL
to	NULL
the	NULL
same	NULL
SaclI-Nsil	NULL
fragment	NULL
(	NULL
bp	NULL
1179-1734	NULL
)	NULL
.	NULL

For	NULL
the	NULL
ZAP-7OKD	NULL
construct	NULL
,	NULL
the	NULL
first	NULL
PCR	NULL
used	NULL
a	NULL
5	NULL
primer	NULL
,	NULL
including	NULL
bp	NULL
1141-1160	NULL
upstream	NULL
of	NULL
a	NULL
SacI	NULL
site	NULL
and	NULL
a	NULL
3	NULL
'	NULL
primer	NULL
containing	NULL
a	NULL
mutation	NULL
of	NULL
Asp-461	NULL
(	NULL
AAC	NULL
)	NULL
to	NULL
Asn	NULL
(	NULL
GAC	NULL
)	NULL
,	NULL
encompassing	NULL
bp	NULL
1583-1608	NULL
.	NULL

The	NULL
second	NULL
PCR	NULL
used	NULL
a	NULL
5	NULL
primer	NULL
complementary	NULL
to	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
of	NULL
the	NULL
first	NULL
PCR	NULL
and	NULL
a	NULL
3	NULL
'	NULL
primer	NULL
including	NULL
bp	NULL
1796-1815	NULL
downstream	NULL
from	NULL
the	NULL
Nsil	NULL
site	NULL
.	NULL

For	NULL
the	NULL
ZAP-70FF	NULL
construct	NULL
,	NULL
two	NULL
other	NULL
complementary	NULL
inter	NULL
32645	NULL
nal	NULL
primers	NULL
creating	NULL
a	NULL
double	NULL
mutation	NULL
of	NULL
Tyr-492/4938	NULL
(	NULL
TACTAC	NULL
)	NULL
to	NULL
FF	NULL
(	NULL
TTCTTC	NULL
)	NULL
and	NULL
encompassing	NULL
bp	NULL
16783-1697	NULL
were	NULL
used	NULL
.	NULL

The	NULL
final	NULL
PCR	NULL
products	NULL
were	NULL
restricted	NULL
by	NULL
Sacl	NULL
and	NULL
Nsil	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
558-bp	NULL
fragment	NULL
ligated	NULL
with	NULL
both	NULL
a	NULL
466-bp	NULL
Mi/ul-Sacl	NULL
fragment	NULL
(	NULL
bp	NULL
718-1179	NULL
)	NULL
and	NULL
a	NULL
3.8-kb	NULL
ZAP-70-VSV-G	NULL
pBS	NULL
fragment	NULL
restricted	NULL
with	NULL
M/ul	NULL
and	NULL
Nsil	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
all	NULL
PCR	NULL
products	NULL
and	NULL
the	NULL
junctions	NULL
were	NULL
confirmed	NULL
by	NULL
standard	NULL
dideoxy	NULL
DNA	NULL
sequencing	NULL
.	NULL

Cell	NULL
Transfection	NULL
,	NULL
Activation	NULL
,	NULL
and	NULL
Luciferase	NULL
Assays-Transient	NULL
transfections	NULL
were	NULL
performed	NULL
by	NULL
electroporating	NULL
(	NULL
at	NULL
260	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
)	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
a	NULL
Gene	NULL
Pulse	NULL
cuvette	NULL
(	NULL
Bio-Rad	NULL
)	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
pSRapuro	NULL
vector	NULL
without	NULL
insert	NULL
(	NULL
empty	NULL
vector	NULL
)	NULL
or	NULL
containing	NULL
ZAP-7ZOWT	NULL
or	NULL
mutants	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
NFAT-luciferase	NULL
plasmid	NULL
,	NULL
and	NULL
30	NULL
ug	NULL
of	NULL
pSV-gal	NULL
plasmid	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
equalized	NULL
with	NULL
empty	NULL
pSRapuro	NULL
vector	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
growth	NULL
medium	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
seeded	NULL
at	NULL
10°	NULL
cells/100	NULL
ul	NULL
into	NULL
U-bottomed	NULL
,	NULL
96-well	NULL
plates	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
h	NULL
with	NULL
101.5.2	NULL
anti-TCR	NULL
mAb	NULL
precoated	NULL
to	NULL
wells	NULL
at	NULL
1:1000	NULL
dilution	NULL
of	NULL
ascites	NULL
or	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

(	NULL
Sigma	NULL
)	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

B-Galactosidase	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
,	NULL
determined	NULL
in	NULL
duplicate	NULL
samples	NULL
using	NULL
an	NULL
automated	NULL
luminometer	NULL
(	NULL
Lumat	NULL
LB	NULL
9501	NULL
,	NULL
EG	NULL
&	NULL
G	NULL
Berthod	NULL
,	NULL
Wildbad	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
was	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
(	NULL
AU	NULL
)	NULL
after	NULL
normalization	NULL
to	NULL
the	NULL
B-galactosidase	NULL
values	NULL
to	NULL
correct	NULL
for	NULL
variation	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

For	NULL
stable	NULL
transfections	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
resuspended	NULL
at	NULL
10	NULL
``	NULL
cells/ml	NULL
in	NULL
HeBS	NULL
buffer	NULL
,	NULL
pH	NULL
7.05	NULL
(	NULL
0.8	NULL
my	NULL
NaHPO	NULL
,	NULL
.2H,0	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCl	NULL
,	NULL
and	NULL
5.5	NULL
mM	NULL
D-glucose	NULL
)	NULL
,	NULL
mixed	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
,	NULL
and	NULL
electroporated	NULL
at	NULL
250	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
in	NULL
a	NULL
Gene	NULL
Pulse	NULL
cuvette	NULL
.	NULL

After	NULL
72	NULL
h	NULL
in	NULL
growth	NULL
medium	NULL
,	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
10	NULL
%	NULL
cells/well	NULL
in	NULL
flat-bottomed	NULL
,	NULL
96-well	NULL
plates	NULL
and	NULL
placed	NULL
under	NULL
selection	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ug/ml	NULL
puromycin	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Puromycin-resistant	NULL
clones	NULL
expressing	NULL
ZAP-70-tag	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
CD3	NULL
.	NULL

Immunoprecipitations	NULL
and	NULL
Immunoblotting-Jurkat	NULL
cell	NULL
transfectants	NULL
were	NULL
preincubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
101.5.2	NULL
at	NULL
1:200	NULL
dilution	NULL
of	NULL
ascites	NULL
for	NULL
2-3	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
immediately	NULL
centrifuged	NULL
and	NULL
solubilized	NULL
at	NULL
10°	NULL
cells/ml	NULL
for	NULL
15	NULL
min	NULL
in	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EGTA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
inhibitors	NULL
of	NULL
proteases	NULL
and	NULL
phosphatases	NULL
(	NULL
10	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
mM	NULL
Pefabloc-se	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
mM	NULL
Na	NULL
,	NULL
P,0	NULL
,	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
NaVO	NULL
,	NULL
)	NULL
.	NULL

Postnuclear	NULL
lysates	NULL
were	NULL
precleared	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
the	NULL
indicated	NULL
antisera	NULL
preadsorbed	NULL
to	NULL
protein	NULL
A-Sepharose	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

For	NULL
precipitation	NULL
of	NULL
p56	NULL
``	NULL
**SH2-bound	NULL
pro-teins	NULL
,	NULL
maltose-binding	NULL
protein-p56	NULL
``	NULL
**SH2	NULL
fusion	NULL
protein	NULL
covalently	NULL
coupled	NULL
to	NULL
Sepharose	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
(	NULL
at	NULL
3-5	NULL
mg/m	NULL
!	NULL

of	NULL
beads	NULL
)	NULL
was	NULL
used	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
,	NULL
twice	NULL
with	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
boiled	NULL
in	NULL
sample	NULL
buffer	NULL
before	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Immunoblotting	NULL
and	NULL
detection	NULL
of	NULL
proteins	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
where	NULL
'*	NULL
``	NULL
I-labeled	NULL
protein	NULL
A	NULL
(	NULL
2-5	NULL
Ci	NULL
)	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
was	NULL
used	NULL
,	NULL
blots	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
skimmed	NULL
milk	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
2.5	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
buffer	NULL
containing	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

Quantitation	NULL
of	NULL
***I-labeled	NULL
proteins	NULL
was	NULL
performed	NULL
using	NULL
Image	NULL
Quant	NULL
software	NULL
after	NULL
scanning	NULL
in	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

In	NULL
Vitro	NULL
Kinase	NULL
Assays-Anti-VSV-G	NULL
tag	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
,	NULL
once	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
74	NULL
,	NULL
0.5	NULL
M	NULL
LiCl	NULL
and	NULL
once	NULL
in	NULL
kinase	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
MnCl	NULL
,	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
in	NULL
25	NULL
ul	NULL
of	NULL
kinase	NULL
buffer	NULL
containing	NULL
10	NULL
uCi	NULL
of	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
ATP	NULL
(	NULL
4500	NULL
Ci/mmol	NULL
,	NULL
ICN	NULL
Pharmaceuticals	NULL
,	NULL
Orsay	NULL
,	NULL
France	NULL
)	NULL
,	NULL
5	NULL
uM	NULL
of	NULL
cold	NULL
ATP	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
band	NULL
3	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
R.	NULL
Wange	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
as	NULL
an	NULL
exogenous	NULL
substrate	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
adding	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
2	NULL
X	NULL
LaemmIi	NULL
sample	NULL
buffer	NULL
containing	NULL
200	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
and	NULL
boiling	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
gels	NULL
were	NULL
treated	NULL
with	NULL
KOH	NULL
for	NULL
1	NULL
h	NULL
at	NULL
55	NULL
°C	NULL
and	NULL
dried	NULL
,	NULL
and	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Quantitation	NULL
of	NULL
'*	NULL
``	NULL
I-labeled	NULL
ZAP-70	NULL
and	NULL
*°P-labeled	NULL
ZAP-70	NULL
and	NULL
band	NULL
3	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Gels	NULL
were	NULL
stained	NULL
with	NULL
Coomassie	NULL
Blue	NULL
to	NULL
ascertain	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
band	NULL
3	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
Intracellular	NULL
Free	NULL
Calcium	NULL
Concentration-Measurements	NULL
of	NULL
free	NULL
cytosolic	NULL
calcium	NULL
concentration	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
method	NULL
described	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Three	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
10	NULL
``	NULL
/ml	NULL
in	NULL
RPMI	NULL
without	NULL
serum	NULL
containing	NULL
20	NULL
uM	NULL
of	NULL
the	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
32646	NULL
180	NULL
|	NULL
A	NULL
{	NULL
ZAP-70WT	NULL
1607	NULL
ZAP-70FF	NULL
Fo	NULL
ZAP-70KD	NULL
~	NULL
4404	NULL
35	NULL
i	NULL
>	NULL
1207	NULL
3	NULL
led	NULL
1007	NULL
jod	NULL
$	NULL
CG	NULL
oo	NULL
8057	NULL
3	NULL
|	NULL
=	NULL
so-®	NULL
12	NULL
*	NULL
407	NULL
@	NULL
CC	NULL
20	NULL
o	NULL
3	NULL
1	NULL
5	NULL
Expression	NULL
vector	NULL
(	NULL
ug	NULL
)	NULL
220	NULL
2001	NULL
B	NULL
O	NULL
zar7z0owt	NULL
ZAP-70FF	NULL
$	NULL
180-4	NULL
3	NULL
zaPr70kD	NULL
>	NULL
160	NULL
>	NULL
#	NULL
1407	NULL
o	NULL
o	NULL
1297	NULL
®	NULL
g	NULL
100	NULL
-	NULL
y/J	NULL
S	NULL
#	NULL
3	NULL
so	NULL
{	NULL
%	NULL
g	NULL
so-	NULL
#	NULL
30	NULL
``	NULL
P	NULL
E	NULL
40	NULL
7	NULL
¢	NULL
so	NULL
g	NULL
0-0,2	NULL
1	NULL
5	NULL
Expression	NULL
vector	NULL
(	NULL
ug	NULL
)	NULL
100	NULL
1	NULL
C	NULL
C	NULL
zaAP70WT	NULL
90	NULL
7	NULL
<	NULL
~~	NULL
80	NULL
4	NULL
>	NULL
s	NULL
797	NULL
‘	NULL
05	NULL
©	NULL
604	NULL
P	NULL
©	NULL
507	NULL
£2	NULL
4	NULL
§	NULL
404	NULL
--	NULL
-8	NULL
so-E	NULL
«	NULL
®	NULL
-I	NULL
&	NULL
20-10	NULL
7	NULL
Ill	NULL
o	NULL
.	NULL

0,2	NULL
1	NULL
5	NULL
Expression	NULL
vector	NULL
(	NULL
ug	NULL
)	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
wild-type	NULL
ZAP-70	NULL
and	NULL
mutants	NULL
on	NULL
NFAT	NULL
activation	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NFAT-luciferase	NULL
and	NULL
pSV	NULL
--	NULL
galactosidase	NULL
reporter	NULL
plasmids	NULL
(	NULL
10	NULL
and	NULL
30	NULL
ug	NULL
,	NULL
respectively	NULL
)	NULL
together	NULL
with	NULL
pSRapuro	NULL
expression	NULL
vector	NULL
either	NULL
empty	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
or	NULL
containing	NULL
the	NULL
ZAP-70	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Activation	NULL
calcium-sensitive	NULL
fluorescent	NULL
dye	NULL
fluo	NULL
3-acetoxymethyl	NULL
ester	NULL
(	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
RPMI	NULL
containing	NULL
1	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
at	NULL
1.5	NULL
X	NULL
10°	NULL
cell/ml	NULL
and	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
(	NULL
101.5.2	NULL
)	NULL
at	NULL
1:500	NULL
dilution	NULL
of	NULL
ascites	NULL
or	NULL
thapsigargin	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
.	NULL

Mean	NULL
fluorescence	NULL
intensity	NULL
(	NULL
F	NULL
)	NULL
was	NULL
recorded	NULL
every	NULL
30	NULL
s	NULL
in	NULL
a	NULL
FACScan	NULL
cytometer	NULL
(	NULL
Beckton	NULL
&	NULL
Dickinson	NULL
Co.	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
represents	NULL
the	NULL
average	NULL
response	NULL
of	NULL
2000	NULL
viable	NULL
cells	NULL
.	NULL

Each	NULL
recording	NULL
was	NULL
calibrated	NULL
by	NULL
determining	NULL
the	NULL
maximal	NULL
uptake	NULL
of	NULL
calcium	NULL
(	NULL
Fmax	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
ug/ml	NULL
calcium	NULL
ionophore	NULL
A283187	NULL
as	NULL
well	NULL
as	NULL
the	NULL
level	NULL
of	NULL
autofluorescence	NULL
(	NULL
Fmin	NULL
)	NULL
,	NULL
after	NULL
quenching	NULL
fluo	NULL
S-ace-toxymethyl	NULL
ester	NULL
fluorescence	NULL
with	NULL
1	NULL
mM	NULL
Mn2*	NULL
.	NULL

Intracellular	NULL
calcium	NULL
concentration	NULL
,	NULL
[	NULL
Ca®*	NULL
]	NULL
1	NULL
;	NULL
,	NULL
was	NULL
calculated	NULL
using	NULL
the	NULL
equation	NULL
(	NULL
80	NULL
)	NULL
:	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
=	NULL
K	NULL
,	NULL
(	NULL
F	NULL
-	NULL
Fmin	NULL
)	NULL
/	NULL
(	NULL
Fmax	NULL
-	NULL
F	NULL
)	NULL
,	NULL
where	NULL
K	NULL
,	NULL
is	NULL
the	NULL
dissociation	NULL
constant	NULL
of	NULL
fluo	NULL
8-acetoxymethyl	NULL
ester	NULL
set	NULL
to	NULL
400	NULL
nM	NULL
.	NULL

RESULTS	NULL
Overexpression	NULL
of	NULL
a	NULL
Y492F/Y493F	NULL
ZAP-70	NULL
Mutant	NULL
in	NULL
Jurkat	NULL
Cells	NULL
Inhibits	NULL
TCR-induced	NULL
NFAT	NULL
Activation-A	NULL
transient	NULL
transfection	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
whether	NULL
TCR-mediated	NULL
activation	NULL
of	NULL
Jurkat	NULL
cells	NULL
was	NULL
affected	NULL
by	NULL
overexpressing	NULL
ZAP-70	NULL
in	NULL
which	NULL
both	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
were	NULL
mutated	NULL
to	NULL
F	NULL
(	NULL
ZAP-70FF	NULL
mutant	NULL
)	NULL
.	NULL

As	NULL
a	NULL
read-out	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
activation	NULL
of	NULL
NFAT	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
enhancing	NULL
IL-2	NULL
gene	NULL
transcription	NULL
(	NULL
31	NULL
)	NULL
.	NULL

We	NULL
used	NULL
an	NULL
NFAT-luciferase	NULL
reporter	NULL
construct	NULL
(	NULL
NFAT-luc	NULL
)	NULL
containing	NULL
a	NULL
trimer	NULL
of	NULL
an	NULL
IL-2-derived	NULL
cis-acting	NULL
element	NULL
that	NULL
binds	NULL
the	NULL
NFAT	NULL
transcription	NULL
complex	NULL
(	NULL
31	NULL
)	NULL
.	NULL

A	NULL
constitutive	NULL
SV40	NULL
promoter-B-galactosidase	NULL
reporter	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
used	NULL
to	NULL
express	NULL
ZAP-70	NULL
,	NULL
together	NULL
with	NULL
NFAT-luc	NULL
,	NULL
displayed	NULL
an	NULL
approximately	NULL
100-fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
set	NULL
to	NULL
100	NULL
%	NULL
,	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
when	NULL
stimulated	NULL
with	NULL
an	NULL
optimal	NULL
dose	NULL
of	NULL
anti-TCR	NULL
mAb	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
vector	NULL
containing	NULL
the	NULL
ZAP-70FF	NULL
mutant	NULL
cDNA	NULL
markedly	NULL
reduced	NULL
TCR-stimulated	NULL
luciferase	NULL
activity	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
,	NULL
whereas	NULL
no	NULL
inhibition	NULL
was	NULL
observed	NULL
with	NULL
wild-type	NULL
ZAP-70	NULL
cDNA	NULL
(	NULL
ZAP-7ZOWT	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
dose-dependent	NULL
inhibition	NULL
was	NULL
also	NULL
found	NULL
when	NULL
expressing	NULL
a	NULL
kinase-defective	NULL
ZAP-70	NULL
mutant	NULL
(	NULL
ZAP-70KD	NULL
)	NULL
in	NULL
which	NULL
Asp-461	NULL
,	NULL
a	NULL
highly	NULL
conserved	NULL
residue	NULL
in	NULL
the	NULL
kinase	NULL
domain	NULL
of	NULL
PTKs	NULL
essential	NULL
for	NULL
catalytic	NULL
activity	NULL
,	NULL
was	NULL
substituted	NULL
by	NULL
N	NULL
(	NULL
82	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
ZAP-70	NULL
constructs	NULL
,	NULL
all	NULL
VSV-G-tagged	NULL
at	NULL
their	NULL
COOH	NULL
termini	NULL
(	NULL
see	NULL
``	NULL
Ma-terials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
,	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
no	NULL
apparent	NULL
inhibition	NULL
was	NULL
noticed	NULL
on	NULL
constitutive	NULL
B-galactosidase	NULL
activity	NULL
in	NULL
any	NULL
one	NULL
of	NULL
the	NULL
transfections	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
thus	NULL
excluding	NULL
a	NULL
generalized	NULL
suppres-sive	NULL
effect	NULL
on	NULL
transcription	NULL
by	NULL
the	NULL
expressed	NULL
mutants	NULL
.	NULL

Fig	NULL
.	NULL

1B	NULL
shows	NULL
that	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
ZAP-70	NULL
mutants	NULL
on	NULL
NFAT	NULL
activity	NULL
was	NULL
essentially	NULL
overcome	NULL
by	NULL
stimulating	NULL
transfected	NULL
cells	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
calcium	NULL
ionophore	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
pharmacological	NULL
agents	NULL
are	NULL
required	NULL
for	NULL
inducing	NULL
an	NULL
active	NULL
NFAT	NULL
transcriptional	NULL
complex	NULL
,	NULL
bypassing	NULL
proximal	NULL
TCR-induced	NULL
signals	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
experiments	NULL
cDNA	NULL
of	NULL
ZAP-70	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
ZAP-70	NULL
mutants	NULL
(	NULL
FF	NULL
or	NULL
KD	NULL
)	NULL
at	NULL
the	NULL
indicated	NULL
doses	NULL
.	NULL

The	NULL
DNA	NULL
content	NULL
of	NULL
each	NULL
transfection	NULL
was	NULL
made	NULL
even	NULL
with	NULL
empty	NULL
expression	NULL
vector	NULL
.	NULL

After	NULL
24	NULL
h	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
precoated	NULL
to	NULL
plastic	NULL
wells	NULL
(	NULL
A	NULL
)	NULL
or	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
plus	NULL
calcium	NULL
ionophore	NULL
(	NULL
A23187	NULL
)	NULL
(	NULL
2	NULL
pg/ml	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
and	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
to	NULL
correct	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Basal	NULL
luciferase	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
empty	NULL
vector	NULL
or	NULL
ZAP-70	NULL
mutants	NULL
was	NULL
routinely	NULL
about	NULL
300	NULL
AU	NULL
,	NULL
whereas	NULL
it	NULL
increased	NULL
with	NULL
the	NULL
dose	NULL
of	NULL
ZAP-7Z0WT	NULL
construct	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Data	NULL
in	NULL
A	NULL
and	NULL
B	NULL
indicate	NULL
in	NULL
percentage	NULL
the	NULL
induced	NULL
luciferase	NULL
activity	NULL
measured	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
ZAP-7OWT	NULL
or	NULL
mutants	NULL
divided	NULL
by	NULL
the	NULL
activity	NULL
measured	NULL
with	NULL
empty	NULL
expression	NULL
vector	NULL
(	NULL
approximately	NULL
30,000	NULL
AU	NULL
in	NULL
A	NULL
and	NULL
100,000	NULL
AU	NULL
in	NULL
B	NULL
)	NULL
and	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
two	NULL
to	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

C	NULL
,	NULL
constitutive	NULL
luciferase	NULL
activity	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
ZAP-TZOWT	NULL
construct	NULL
represents	NULL
in	NULL
percentage	NULL
the	NULL
luciferase	NULL
activity	NULL
of	NULL
unstimulated	NULL
cells	NULL
divided	NULL
by	NULL
the	NULL
activity	NULL
after	NULL
anti-TCR	NULL
stimulation	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Bars	NULL
,	NULL
S.E	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
ZAP-70	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Activation	NULL
FF	NULL
18-22	NULL
ZAP-70tag	NULL
~	NULL
woe	NULL
:	NULL
lts	NULL
Sulen	NULL
ZAP-70end	NULL
``	NULL
ng	NULL
Transfectants	NULL
WT	NULL
15-8	NULL
FF	NULL
18-22	NULL
FF	NULL
10	NULL
KD	NULL
12	NULL
exogenous/endogenous	NULL
1.9	NULL
+	NULL
0.1	NULL
5.0	NULL
£	NULL
0.8	NULL
1.3	NULL
£0.2	NULL
2.6	NULL
£	NULL
0.3	NULL
ZaP-70	NULL
(	NULL
n=3	NULL
)	NULL
(	NULL
n=3	NULL
)	NULL
(	NULL
n=6	NULL
)	NULL
(	NULL
{	NULL
n=4	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Quantitation	NULL
of	NULL
VSV-G-tagged	NULL
ZAP-70	NULL
and	NULL
mutants	NULL
stably	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cell	NULL
transfectants	NULL
and	NULL
comparison	NULL
with	NULL
endogenous	NULL
ZAP-70	NULL
.	NULL

Upper	NULL
panel	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
from	NULL
the	NULL
indicated	NULL
transfectants	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40-containing	NULL
buffer	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-ZAP-70	NULL
antiserum	NULL
(	NULL
4.06	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
7	NULL
%	NULL
polyacrylamide	NULL
SDS-gel	NULL
,	NULL
immunoblotted	NULL
with	NULL
the	NULL
same	NULL
antiserum	NULL
,	NULL
probed	NULL
with	NULL
'**I-labeled	NULL
protein	NULL
A	NULL
,	NULL
and	NULL
exposed	NULL
for	NULL
autoradiography	NULL
.	NULL

ZAP-70tag	NULL
and	NULL
ZAP-70end	NULL
indicate	NULL
the	NULL
relative	NULL
position	NULL
of	NULL
exogenous	NULL
and	NULL
endogenous	NULL
ZAP-70	NULL
,	NULL
respectively	NULL
.	NULL

Lower	NULL
panel	NULL
,	NULL
ratios	NULL
of	NULL
exogenous	NULL
over	NULL
endogenous	NULL
ZAP-70	NULL
expressed	NULL
in	NULL
Jurkat	NULL
transfectants	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
bands	NULL
corresponding	NULL
to	NULL
the	NULL
71-kDa	NULL
(	NULL
ZAP-70tag	NULL
)	NULL
and	NULL
69-kDa	NULL
(	NULL
ZAP-7O0end	NULL
)	NULL
molecular	NULL
species	NULL
was	NULL
performed	NULL
by	NULL
scanning	NULL
the	NULL
blots	NULL
in	NULL
a	NULL
PhosphorImager	NULL
and	NULL
by	NULL
analysis	NULL
with	NULL
Image	NULL
Quant	NULL
software	NULL
for	NULL
analysis	NULL
.	NULL

The	NULL
means	NULL
of	NULL
ratios	NULL
calculated	NULL
from	NULL
the	NULL
indicated	NULL
number	NULL
of	NULL
experiments	NULL
are	NULL
+	NULL
S.E	NULL
.	NULL

suggested	NULL
that	NULL
,	NULL
similarly	NULL
to	NULL
the	NULL
kinase-defective	NULL
ZAP-70	NULL
,	NULL
ZAP-70FF	NULL
acted	NULL
as	NULL
a	NULL
dominant-negative	NULL
mutant	NULL
in	NULL
Jurkat	NULL
cells	NULL
to	NULL
suppress	NULL
TCR-mediated	NULL
NFAT	NULL
activation	NULL
by	NULL
blocking	NULL
proximal	NULL
TCR-stimulated	NULL
signaling	NULL
events	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
ZAP-7ZOWT	NULL
construct	NULL
induced	NULL
a	NULL
substantial	NULL
dose-dependent	NULL
increase	NULL
of	NULL
NFAT	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

At	NULL
the	NULL
maximal	NULL
amount	NULL
of	NULL
ZAP-7ZO0WT	NULL
construct	NULL
tested	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
,	NULL
unstimulated	NULL
cells	NULL
displayed	NULL
an	NULL
NFAT	NULL
activity	NULL
that	NULL
represented	NULL
approximately	NULL
40	NULL
%	NULL
of	NULL
the	NULL
level	NULL
induced	NULL
by	NULL
TCR	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
overexpression	NULL
of	NULL
ZAP-70	NULL
in	NULL
Jurkat	NULL
cells	NULL
is	NULL
sufficient	NULL
per	NULL
se	NULL
to	NULL
activate	NULL
the	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
NFAT	NULL
activation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCR	NULL
cross-linking	NULL
.	NULL

Establishment	NULL
of	NULL
Jurkat	NULL
Cell	NULL
Lines	NULL
Stably	NULL
Expressing	NULL
ZAP-70FF	NULL
Mutant-To	NULL
analyze	NULL
the	NULL
biochemical	NULL
basis	NULL
of	NULL
the	NULL
sup-pressive	NULL
effect	NULL
of	NULL
ZAP-7OFF	NULL
on	NULL
TCR-mediated	NULL
NFAT	NULL
activation	NULL
,	NULL
Jurkat	NULL
cells	NULL
stably	NULL
overexpressing	NULL
this	NULL
mutant	NULL
were	NULL
obtained	NULL
.	NULL

Expression	NULL
of	NULL
VSV-G-tagged	NULL
ZAP-70FF	NULL
was	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
,	NULL
and	NULL
clones	NULL
expressing	NULL
different	NULL
levels	NULL
of	NULL
ZAP-70FF	NULL
but	NULL
comparable	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
CD3	NULL
were	NULL
further	NULL
characterized	NULL
.	NULL

A	NULL
similar	NULL
procedure	NULL
was	NULL
applied	NULL
to	NULL
isolate	NULL
stable	NULL
transfectants	NULL
expressing	NULL
ZAP-7ZOWT	NULL
,	NULL
ZAP-70KD	NULL
mutant	NULL
as	NULL
well	NULL
as	NULL
the	NULL
empty	NULL
vector	NULL
to	NULL
be	NULL
used	NULL
as	NULL
controls	NULL
in	NULL
some	NULL
experiments	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
molecular	NULL
weight	NULL
due	NULL
to	NULL
the	NULL
18-amino	NULL
acid-long	NULL
sequence	NULL
containing	NULL
the	NULL
VSV-G	NULL
tag	NULL
allowed	NULL
us	NULL
to	NULL
resolve	NULL
the	NULL
exogenous	NULL
and	NULL
endogenous	NULL
ZAP-70	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
could	NULL
estimate	NULL
their	NULL
relative	NULL
expression	NULL
levels	NULL
after	NULL
immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
using	NULL
an	NULL
anti-ZAP-70	NULL
antiserum	NULL
and	NULL
revelation	NULL
with	NULL
'	NULL
``	NULL
T-la-beled	NULL
protein	NULL
A	NULL
.	NULL

A	NULL
typical	NULL
autoradiography	NULL
is	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
(	NULL
fop	NULL
)	NULL
and	NULL
shows	NULL
that	NULL
a	NULL
71-kDa	NULL
molecular	NULL
species	NULL
was	NULL
only	NULL
present	NULL
in	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
tagged	NULL
ZAP-70	NULL
(	NULL
WT	NULL
,	NULL
FF	NULL
and	NULL
KD	NULL
)	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
empty	NULL
vector	NULL
(	NULL
JO	NULL
5.2	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
was	NULL
identified	NULL
as	NULL
the	NULL
exogenous	NULL
ZAP-70	NULL
(	NULL
ZAP-70tag	NULL
)	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-tag	NULL
antiserum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
faster	NULL
migrating	NULL
molecular	NULL
species	NULL
of	NULL
69	NULL
kDa	NULL
representing	NULL
endogenous	NULL
ZAP-70	NULL
(	NULL
ZAP-7Oend	NULL
)	NULL
was	NULL
de	NULL
32647	NULL
tected	NULL
in	NULL
all	NULL
transfectants	NULL
.	NULL

The	NULL
71	NULL
kDa:69	NULL
kDa	NULL
ratios	NULL
in	NULL
representative	NULL
transfectants	NULL
expressing	NULL
ZAP-7ZOWT	NULL
,	NULL
ZAP-70FF	NULL
and	NULL
ZAP-70KD	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
(	NULL
bofftom	NULL
)	NULL
.	NULL

FF18-22	NULL
and	NULL
FF1O	NULL
transfectants	NULL
expressed	NULL
5-	NULL
and	NULL
1.3-fold	NULL
excess	NULL
of	NULL
ZAP-70FF	NULL
mutant	NULL
over	NULL
endogenous	NULL
ZAP-70	NULL
,	NULL
respectively	NULL
.	NULL

Expression	NULL
of	NULL
exogenous	NULL
ZAP-7O0WT	NULL
and	NULL
KD	NULL
mutant	NULL
in	NULL
the	NULL
WT1I5-8	NULL
and	NULL
KD12	NULL
transfectants	NULL
were	NULL
about	NULL
1.9-	NULL
and	NULL
2.6-fold	NULL
higher	NULL
than	NULL
endogenous	NULL
ZAP-70	NULL
,	NULL
respectively	NULL
.	NULL

Jurkat	NULL
Cells	NULL
Stably	NULL
Overexpressing	NULL
ZAP-7O0FF	NULL
Mutant	NULL
Are	NULL
Defective	NULL
for	NULL
TCR-induced	NULL
NFAT	NULL
Activation	NULL
and	NULL
Intracellular	NULL
Calcium	NULL
Increase	NULL
-We	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
transfectants	NULL
expressing	NULL
ZAP-70FF	NULL
to	NULL
activate	NULL
NFAT	NULL
upon	NULL
TCR	NULL
triggering	NULL
compared	NULL
to	NULL
JO5.2	NULL
control	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

3A	NULL
shows	NULL
that	NULL
FF18-22	NULL
was	NULL
severely	NULL
impaired	NULL
(	NULL
80-90	NULL
%	NULL
reduction	NULL
)	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
NFAT	NULL
after	NULL
TCR	NULL
stimulation	NULL
,	NULL
whereas	NULL
the	NULL
response	NULL
of	NULL
FF1O	NULL
was	NULL
only	NULL
reduced	NULL
by	NULL
45	NULL
%	NULL
compared	NULL
to	NULL
JO	NULL
5.2	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
levels	NULL
of	NULL
ZAP-70O0FF	NULL
mutant	NULL
expressed	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
experiment	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
indicates	NULL
that	NULL
transfection	NULL
of	NULL
ZAP-7ZOWT	NULL
in	NULL
FF18-22	NULL
cells	NULL
reversed	NULL
NFAT	NULL
activation	NULL
inhibition	NULL
whereas	NULL
the	NULL
empty	NULL
vector	NULL
had	NULL
no	NULL
restoring	NULL
effect	NULL
.	NULL

This	NULL
result	NULL
supports	NULL
the	NULL
conclusion	NULL
that	NULL
the	NULL
strongly	NULL
reduced	NULL
NFAT	NULL
activity	NULL
in	NULL
FF18-22	NULL
cells	NULL
was	NULL
directly	NULL
caused	NULL
by	NULL
ZAP-70FF	NULL
interference	NULL
with	NULL
the	NULL
normal	NULL
function	NULL
of	NULL
ZAP-70	NULL
.	NULL

Because	NULL
the	NULL
levels	NULL
of	NULL
inhibition	NULL
observed	NULL
in	NULL
FF1O	NULL
cells	NULL
were	NULL
rather	NULL
weak	NULL
,	NULL
further	NULL
experiments	NULL
were	NULL
focused	NULL
on	NULL
transfectants	NULL
overexpressing	NULL
ZAP-7O0FF	NULL
.	NULL

NFAT	NULL
activation	NULL
requires	NULL
both	NULL
calcium/calcineurin-	NULL
and	NULL
Ras-regulated	NULL
pathways	NULL
(	NULL
34	NULL
)	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
initially	NULL
investigated	NULL
whether	NULL
TCR-induced	NULL
increase	NULL
of	NULL
free	NULL
cytosolic	NULL
calcium	NULL
concentration	NULL
(	NULL
[	NULL
Ca2+	NULL
]	NULL
i	NULL
)	NULL
was	NULL
inhibited	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
ZAP-7OFF	NULL
overexpression	NULL
.	NULL

A	NULL
typical	NULL
experiment	NULL
is	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
.	NULL

JQ	NULL
5.2	NULL
cells	NULL
demonstrated	NULL
a	NULL
transient	NULL
and	NULL
marked	NULL
[	NULL
Ca2+	NULL
]	NULL
i	NULL
in-crease	NULL
,	NULL
later	NULL
reaching	NULL
a	NULL
plateau	NULL
at	NULL
a	NULL
lower	NULL
level	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
FF18-22	NULL
cells	NULL
responded	NULL
by	NULL
a	NULL
weak	NULL
,	NULL
yet	NULL
sustained	NULL
,	NULL
increase	NULL
in	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
,	NULL
reaching	NULL
a	NULL
maximum	NULL
which	NULL
was	NULL
only	NULL
18	NULL
%	NULL
of	NULL
that	NULL
of	NULL
control	NULL
cells	NULL
.	NULL

Similar	NULL
reductions	NULL
of	NULL
[	NULL
Ca2+	NULL
]	NULL
i	NULL
increase	NULL
were	NULL
seen	NULL
with	NULL
another	NULL
clone	NULL
,	NULL
FF18-21	NULL
,	NULL
which	NULL
expressed	NULL
levels	NULL
of	NULL
ZAP-70FF	NULL
comparable	NULL
to	NULL
those	NULL
detected	NULL
in	NULL
FF18-22	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
thapsigargin	NULL
,	NULL
a	NULL
drug	NULL
able	NULL
to	NULL
induce	NULL
calcium	NULL
release	NULL
from	NULL
internal	NULL
stores	NULL
and	NULL
provoke	NULL
extracellular	NULL
calcium	NULL
influx	NULL
(	NULL
85	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

4B	NULL
shows	NULL
that	NULL
thapsigargin	NULL
(	NULL
1	NULL
um	NULL
)	NULL
induced	NULL
[	NULL
Ca**	NULL
]	NULL
;	NULL
increase	NULL
in	NULL
FF18-22	NULL
at	NULL
even	NULL
higher	NULL
levels	NULL
than	NULL
in	NULL
JO	NULL
5.2	NULL
cells	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
attempted	NULL
to	NULL
reverse	NULL
the	NULL
inhibition	NULL
by	NULL
adding	NULL
either	NULL
calcium	NULL
ionophore	NULL
or	NULL
PMA	NULL
to	NULL
TCR-stimulated	NULL
ZAP-70FF-expressing	NULL
cells	NULL
to	NULL
test	NULL
the	NULL
possibility	NULL
that	NULL
only	NULL
one	NULL
of	NULL
the	NULL
two	NULL
pathways	NULL
leading	NULL
to	NULL
NFAT	NULL
activation	NULL
(	NULL
e.g	NULL
.	NULL

calcineurin	NULL
or	NULL
Ras	NULL
)	NULL
was	NULL
blocked	NULL
.	NULL

Neither	NULL
calcium	NULL
ionophore	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
nor	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
treatment	NULL
was	NULL
able	NULL
to	NULL
restore	NULL
the	NULL
response	NULL
when	NULL
combined	NULL
with	NULL
anti-TCR	NULL
stimulation	NULL
,	NULL
compared	NULL
with	NULL
similarly	NULL
treated	NULL
JO	NULL
5.2	NULL
cells	NULL
.	NULL

Comprehensively	NULL
,	NULL
these	NULL
data	NULL
suggested	NULL
that	NULL
ZAP-7O0FF	NULL
mutant	NULL
inhibited	NULL
both	NULL
calcium/calcineurin	NULL
and	NULL
PMA	NULL
(	NULL
e.g	NULL
.	NULL

most	NULL
likely	NULL
protein	NULL
kinase	NULL
C/Ras	NULL
)	NULL
regulated	NULL
pathways	NULL
needed	NULL
to	NULL
form	NULL
an	NULL
active	NULL
NFAT	NULL
transcriptional	NULL
complex	NULL
.	NULL

The	NULL
ZAP-7Z0FF	NULL
Mutant	NULL
Binds	NULL
to	NULL
the	NULL
TCR	NULL
{	NULL
Subunit	NULL
and	NULL
Can	NULL
Be	NULL
Tyrosine	NULL
-phosphorylated-To	NULL
investigate	NULL
whether	NULL
more	NULL
proximal	NULL
TCR-mediated	NULL
signaling	NULL
events	NULL
were	NULL
inhibited	NULL
,	NULL
we	NULL
first	NULL
asked	NULL
if	NULL
the	NULL
ZAP-7ZOFF	NULL
mutant	NULL
was	NULL
still	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
TCR	NULL
£	NULL
subunit	NULL
and	NULL
to	NULL
be	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
after	NULL
TCR	NULL
stimulation	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
anti-	NULL
{	NULL
immunoprecipitates	NULL
from	NULL
untreated	NULL
and	NULL
TCR-stimulated	NULL
FF18-22	NULL
and	NULL
control	NULL
JO	NULL
5.2	NULL
cell	NULL
transfectants	NULL
were	NULL
analyzed	NULL
by	NULL
anti-phosphotyrosine	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

JO	NULL
5.2	NULL
cells	NULL
displayed	NULL
a	NULL
weak	NULL
basal	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
/	NULL
that	NULL
was	NULL
substantially	NULL
increased	NULL
after	NULL
stimulation	NULL
with	NULL
an	NULL
anti-TCR	NULL
mAb	NULL
and	NULL
led	NULL
to	NULL
the	NULL
recruitment	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
32648	NULL
ZAP-70	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Activation	NULL
140	NULL
100	NULL
A	NULL
C	NULL
medium	NULL
B	NULL
120	NULL
-	NULL
EH	NULL
anti-tcr	NULL
anti-TCR+	NULL
A23187	NULL
so	NULL
o	NULL
A	NULL
0	NULL
C	NULL
§	NULL
100	NULL
{	NULL
to	NULL
®	NULL
g	NULL
60-®	NULL
so-	NULL
.	NULL

$	NULL
'	NULL
o	NULL
3	NULL
a	NULL
so	NULL
4	NULL
E	NULL
40	NULL
{	NULL
I	NULL
©	NULL
E	NULL
40	NULL
{	NULL
5	NULL
&	NULL
e	NULL
20	NULL
20	NULL
{	NULL
o-	NULL
o-	NULL
ea	NULL
105.2	NULL
FF10	NULL
FF18-22	NULL
FF18-22	NULL
FF18-22	NULL
+	NULL
vector	NULL
+	NULL
ZAP-7OWT	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Inhibition	NULL
of	NULL
TCR-induced	NULL
NFAT	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
ZAP-70FF	NULL
mutant	NULL
.	NULL

A	NULL
,	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
NFAT-lue	NULL
and	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
pSV-Bgal	NULL
reporter	NULL
plasmids	NULL
as	NULL
a	NULL
control	NULL
of	NULL
transfection	NULL
efficiency	NULL
.	NULL

Twenty-four	NULL
h	NULL
after	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
divided	NULL
equally	NULL
and	NULL
treated	NULL
with	NULL
medium	NULL
,	NULL
anti-TCR	NULL
mAb	NULL
,	NULL
anti-TCR	NULL
plus	NULL
calcium	NULL
ionophore	NULL
(	NULL
A23187	NULL
,	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
plus	NULL
calcium	NULL
ionophore	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
8	NULL
h	NULL
and	NULL
lysed	NULL
;	NULL
then	NULL
luciferase	NULL
and	NULL
-galactosidase	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

Basal	NULL
and	NULL
stimuli-induced	NULL
luciferase	NULL
activities	NULL
in	NULL
each	NULL
cell	NULL
line	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
maximal	NULL
activity	NULL
obtained	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
ionophore	NULL
;	NULL
maximal	NULL
luciferase	NULL
activities	NULL
for	NULL
JO	NULL
5.2	NULL
,	NULL
FF18-22	NULL
,	NULL
and	NULL
FF1O	NULL
cells	NULL
were	NULL
approximately	NULL
43,000	NULL
,	NULL
35,000	NULL
,	NULL
and	NULL
14,000	NULL
AU	NULL
,	NULL
respectively	NULL
(	NULL
with	NULL
S.E	NULL
.	NULL

not	NULL
exceeding	NULL
20	NULL
%	NULL
)	NULL
.	NULL

TCR-induced	NULL
NFAT	NULL
activity	NULL
in	NULL
JO	NULL
5.2	NULL
cells	NULL
was	NULL
found	NULL
to	NULL
be	NULL
very	NULL
close	NULL
(	NULL
about	NULL
90	NULL
%	NULL
)	NULL
to	NULL
that	NULL
measured	NULL
with	NULL
PMA	NULL
plus	NULL
ionophore	NULL
in	NULL
these	NULL
experimental	NULL
conditions	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
of	NULL
values	NULL
determined	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Bars	NULL
,	NULL
S.E	NULL
.	NULL

B	NULL
,	NULL
reversion	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
TCR-induced	NULL
NFAT	NULL
activity	NULL
in	NULL
FF18-22	NULL
cells	NULL
by	NULL
transfection	NULL
with	NULL
ZAP-7ZOWT-containing	NULL
expression	NULL
vector	NULL
.	NULL

FF18-22	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
reporter	NULL
plasmids	NULL
as	NULL
above	NULL
together	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
empty	NULL
or	NULL
ZAP-ZOWT	NULL
cDNA-containing	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
after	NULL
anti-TCR	NULL
stimulation	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
maximal	NULL
luciferase	NULL
activity	NULL
measured	NULL
with	NULL
PMA	NULL
plus	NULL
calcium	NULL
ionophore	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
presented	NULL
of	NULL
three	NULL
that	NULL
gave	NULL
similar	NULL
results	NULL
(	NULL
recovery	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
FF18-22	NULL
transfected	NULL
with	NULL
ZAP-7O0WT	NULL
ranged	NULL
between	NULL
45	NULL
and	NULL
80	NULL
%	NULL
)	NULL
.	NULL

of	NULL
ZAP-70	NULL
(	NULL
ZAP-70end	NULL
)	NULL
.	NULL

Remarkably	NULL
,	NULL
in	NULL
unstimulated	NULL
FF18-22	NULL
,	NULL
the	NULL
{	NULL
chain	NULL
was	NULL
strongly	NULL
tyrosine	NULL
-phosphorylated	NULL
and	NULL
was	NULL
associated	NULL
with	NULL
ZAP-70FF	NULL
,	NULL
itself	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
.	NULL

Upon	NULL
TCR	NULL
activation	NULL
,	NULL
phosphorylated	NULL
&	NULL
and	NULL
ZAP-70FF	NULL
in-creased	NULL
,	NULL
and	NULL
a	NULL
69-kDa	NULL
species	NULL
migrating	NULL
as	NULL
endogenous	NULL
ZAP-70	NULL
also	NULL
appeared	NULL
.	NULL

The	NULL
elevated	NULL
basal	NULL
and	NULL
TCR-induced	NULL
phosphorylation	NULL
of	NULL
{	NULL
in	NULL
FF18-22	NULL
cells	NULL
was	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
the	NULL
overexpression	NULL
of	NULL
ZAP-70FF	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
FF1O	NULL
cells	NULL
that	NULL
expressed	NULL
approximately	NULL
5-fold	NULL
less	NULL
mutant	NULL
basal	NULL
as	NULL
well	NULL
as	NULL
induced	NULL
phosphorylation	NULL
of	NULL
£	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
control	NULL
JO	NULL
5.2	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
ZAP-70FF	NULL
was	NULL
fully	NULL
able	NULL
to	NULL
associate	NULL
to	NULL
£	NULL
and	NULL
that	NULL
,	NULL
when	NULL
overex-pressed	NULL
,	NULL
it	NULL
was	NULL
predominantly	NULL
binding	NULL
to	NULL
/	NULL
compared	NULL
to	NULL
the	NULL
endogenous	NULL
wild-type	NULL
ZAP-70	NULL
,	NULL
providing	NULL
,	NULL
therefore	NULL
,	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
inhibitory	NULL
effects	NULL
on	NULL
downstream	NULL
signaling	NULL
events	NULL
.	NULL

ZAP-70FF	NULL
could	NULL
still	NULL
be	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
on	NULL
tyrosine	NULL
residue	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
i7	NULL
vitro	NULL
autophosphorylation	NULL
capacity	NULL
of	NULL
ZAP-70FF	NULL
and	NULL
its	NULL
kinase	NULL
activity	NULL
on	NULL
the	NULL
exogenous	NULL
substrate	NULL
band	NULL
3	NULL
and	NULL
compared	NULL
them	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
ZAP-7OWT	NULL
and	NULL
ZAP-7ZO0KD	NULL
.	NULL

Anti-tag	NULL
immunoprecipitates	NULL
from	NULL
the	NULL
transfectants	NULL
FF18-22	NULL
,	NULL
WT15.8	NULL
,	NULL
and	NULL
KD12	NULL
were	NULL
split	NULL
and	NULL
subjected	NULL
to	NULL
either	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
or	NULL
to	NULL
a	NULL
quantitative	NULL
immunoblotting	NULL
with	NULL
anti-ZAP-70	NULL
antibody	NULL
and	NULL
**	NULL
``	NULL
I-labeled	NULL
protein	NULL
A	NULL
to	NULL
normalize	NULL
for	NULL
the	NULL
same	NULL
amounts	NULL
of	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
ZAP-70KD	NULL
mutant	NULL
did	NULL
not	NULL
have	NULL
significant	NULL
kinase	NULL
activity	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
autophosphorylation	NULL
of	NULL
ZAP-7OFF	NULL
was	NULL
found	NULL
to	NULL
be	NULL
increased	NULL
with	NULL
respect	NULL
to	NULL
ZAP-7ZO0WT	NULL
(	NULL
after	NULL
normalization	NULL
for	NULL
the	NULL
levels	NULL
of	NULL
precipitated	NULL
ZAP-70-tagged	NULL
proteins	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
ZAP-7O0FF	NULL
displayed	NULL
a	NULL
3-fold	NULL
increased	NULL
basal	NULL
kinase	NULL
specific	NULL
activity	NULL
on	NULL
band	NULL
3	NULL
compared	NULL
with	NULL
ZAP-7ZO0WT	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
found	NULL
with	NULL
ZAP-70FF	NULL
immunoprecipitated	NULL
from	NULL
FF1O	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
may	NULL
at	NULL
least	NULL
in	NULL
part	NULL
explain	NULL
why	NULL
Z-associated	NULL
ZAP-70FF	NULL
was	NULL
highly	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
although	NULL
it	NULL
lacked	NULL
two	NULL
major	NULL
sites	NULL
of	NULL
phosphorylation	NULL
.	NULL

ZAP-70FF	NULL
Mutant	NULL
Is	NULL
Able	NULL
to	NULL
Interact	NULL
with	NULL
p56	NULL
``	NULL
*-We	NULL
have	NULL
previously	NULL
provided	NULL
evidence	NULL
that	NULL
p56	NULL
``	NULL
*	NULL
binds	NULL
directly	NULL
,	NULL
via	NULL
its	NULL
SH2	NULL
domain	NULL
,	NULL
to	NULL
tyrosine-phosphorylated	NULL
,	NULL
Z-associated	NULL
ZAP-70	NULL
shortly	NULL
after	NULL
TCR	NULL
triggering	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

To	NULL
know	NULL
if	NULL
this	NULL
physical	NULL
association	NULL
could	NULL
still	NULL
occur	NULL
between	NULL
p56	NULL
``	NULL
and	NULL
the	NULL
ZAP-70FF	NULL
mutant	NULL
,	NULL
lysates	NULL
of	NULL
FF18-22	NULL
or	NULL
JO5.2	NULL
cells	NULL
,	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
by	NULL
TCR	NULL
cross-linking	NULL
,	NULL
were	NULL
immunoprecipitated	NULL
by	NULL
anti-p56	NULL
``	NULL
*	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
associated	NULL
ZAP-70	NULL
was	NULL
detected	NULL
by	NULL
an	NULL
anti-phosphotyrosine	NULL
immunoblot	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
JO	NULL
5.2	NULL
cells	NULL
,	NULL
tyrosine-phosphorylated	NULL
ZAP-70	NULL
coprecipitated	NULL
with	NULL
p56	NULL
``	NULL
**	NULL
after	NULL
activation	NULL
,	NULL
and	NULL
smaller	NULL
amounts	NULL
were	NULL
seen	NULL
in	NULL
nonactivated	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
above	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
demonstrated	NULL
that	NULL
in	NULL
nonactivated	NULL
FF18-22	NULL
cells	NULL
,	NULL
overexpressed	NULL
ZAP-70FF	NULL
mutant	NULL
was	NULL
already	NULL
tyrosine	NULL
-phosphorylated	NULL
to	NULL
a	NULL
sizable	NULL
level	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
the	NULL
ZAP-70FF	NULL
mutant	NULL
coprecipitated	NULL
with	NULL
p56	NULL
``	NULL
**	NULL
from	NULL
unstimulated	NULL
FF18-22	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
associated	NULL
phosphorylated	NULL
ZAP-70FF	NULL
increased	NULL
after	NULL
TCR	NULL
stimulation	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
p56**	NULL
were	NULL
expressed	NULL
by	NULL
JO	NULL
5.2	NULL
and	NULL
FF18-22	NULL
cells	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
anti-p56	NULL
``	NULL
Western	NULL
blots	NULL
on	NULL
total	NULL
lysates	NULL
of	NULL
stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
p56	NULL
``	NULL
**	NULL
and	NULL
p60	NULL
``	NULL
*	NULL
are	NULL
indicated	NULL
,	NULL
the	NULL
latter	NULL
being	NULL
mostly	NULL
visible	NULL
after	NULL
TCR	NULL
stimulation	NULL
(	NULL
87	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
above	NULL
results	NULL
,	NULL
recombinant	NULL
p56	NULL
``	NULL
**SH2	NULL
domain	NULL
bound	NULL
ZAP-70FF	NULL
before	NULL
activation	NULL
,	NULL
and	NULL
the	NULL
amounts	NULL
increased	NULL
after	NULL
activation	NULL
as	NULL
revealed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
anti-tag	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
are	NULL
not	NULL
required	NULL
for	NULL
p56	NULL
``	NULL
**	NULL
binding	NULL
to	NULL
ZAP-70	NULL
.	NULL

Overexpression	NULL
of	NULL
ZAP-70FF	NULL
Results	NULL
in	NULL
Reduced	NULL
Phosphorylation	NULL
of	NULL
the	NULL
Grb2-associated	NULL
pp36-38	NULL
Phosphoprotein	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
of	NULL
ERKs-Grb2	NULL
,	NULL
a	NULL
well	NULL
characterized	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
ZAP-70	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Activation	NULL
2000	NULL
A	NULL
--	NULL
&	NULL
--	NULL
FF18-22	NULL
--	NULL
-	NULL
JQ	NULL
5.2	NULL
1800	NULL
7	NULL
1600	NULL
1400	NULL
-~	NULL
]	NULL
1200	NULL
-I	NULL
1000	NULL
~	NULL
[	NULL
Ca2+	NULL
]	NULL
;	NULL
(	NULL
nM	NULL
)	NULL
800	NULL
-I	NULL
600	NULL
~	NULL
400	NULL
-I	NULL
-	NULL
«	NULL
«	NULL
4	NULL
--	NULL
anti-TCR	NULL
200	NULL
Time	NULL
(	NULL
min	NULL
.	NULL
)	NULL

2000	NULL
1800	NULL
-	NULL
E3	NULL
1600	NULL
-	NULL
]	NULL
--	NULL
&	NULL
--	NULL
FF18-22	NULL
JO	NULL
5.2	NULL
1400	NULL
~	NULL
=	NULL
1200	NULL
£	NULL
._	NULL
£	NULL
égﬁ	NULL
1000	NULL
-	NULL
a	NULL
?	NULL

h	NULL
&	NULL
CO	NULL
,	NULL
800	NULL
-	NULL
f	NULL
o	NULL
.	NULL

€00	NULL
-	NULL
S	NULL
a	NULL
409	NULL
4	NULL
l	NULL
1	NULL
200	NULL
4	NULL
Time	NULL
(	NULL
min	NULL
.	NULL
)	NULL

Fig	NULL
.	NULL

4	NULL
.	NULL

Overexpression	NULL
of	NULL
ZAP-70FF	NULL
inhibits	NULL
the	NULL
TCR-mediated	NULL
calcium	NULL
flux	NULL
.	NULL

FF18-22	NULL
and	NULL
JO	NULL
5.2	NULL
transfectants	NULL
(	NULL
1.5	NULL
X	NULL
10°	NULL
cells/	NULL
ml	NULL
)	NULL
were	NULL
loaded	NULL
with	NULL
fluo	NULL
3-acetoxymethyl	NULL
ester	NULL
and	NULL
stimulated	NULL
at	NULL
time	NULL
zero	NULL
(	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
)	NULL
with	NULL
an	NULL
anti-TCR	NULL
mAb	NULL
(	NULL
A	NULL
)	NULL
or	NULL
1	NULL
uM	NULL
thapsigargin	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Fluorescence	NULL
of	NULL
cell	NULL
suspension	NULL
was	NULL
monitored	NULL
every	NULL
30	NULL
s	NULL
with	NULL
a	NULL
FACScan	NULL
cytometer	NULL
.	NULL

Intracellular	NULL
free	NULL
calcium	NULL
concentration	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
was	NULL
calibrated	NULL
and	NULL
calculated	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materi-als	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Maximal	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
obtained	NULL
with	NULL
A28187	NULL
ionophore	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
was	NULL
similar	NULL
for	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
repeated	NULL
four	NULL
times	NULL
and	NULL
gave	NULL
similar	NULL
results	NULL
with	NULL
S.E	NULL
.	NULL

of	NULL
the	NULL
maximal	NULL
[	NULL
Ca**1	NULL
;	NULL
<	NULL
30	NULL
%	NULL
.	NULL

adapter	NULL
protein	NULL
playing	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
Ras	NULL
pathway	NULL
(	NULL
38	NULL
)	NULL
,	NULL
associates	NULL
with	NULL
a	NULL
number	NULL
of	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
after	NULL
TCR	NULL
stimulation	NULL
(	NULL
39-43	NULL
)	NULL
.	NULL

These	NULL
phosphoproteins	NULL
,	NULL
including	NULL
pp36-38	NULL
,	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
connecting	NULL
the	NULL
TCR-activated	NULL
PTKs	NULL
to	NULL
several	NULL
signaling	NULL
pathways	NULL
such	NULL
as	NULL
those	NULL
controlled	NULL
by	NULL
Ras	NULL
and	NULL
phospholipase	NULL
Cyl	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
examined	NULL
whether	NULL
in	NULL
cells	NULL
overexpressing	NULL
the	NULL
ZAP-70FF	NULL
mutant	NULL
,	NULL
the	NULL
association	NULL
of	NULL
phosphoproteins	NULL
to	NULL
Grb2	NULL
was	NULL
altered	NULL
.	NULL

Cell	NULL
lysates	NULL
from	NULL
FF18-22	NULL
,	NULL
FF18-21	NULL
,	NULL
and	NULL
control	NULL
JO	NULL
5.2	NULL
transfectants	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
an	NULL
anti-Grb2	NULL
antibody	NULL
,	NULL
and	NULL
associated	NULL
proteins	NULL
were	NULL
revealed	NULL
by	NULL
anti-phosphotyrosine	NULL
immunoblotting	NULL
.	NULL

Fig	NULL
.	NULL

8A	NULL
shows	NULL
that	NULL
in	NULL
J05.2	NULL
cells	NULL
,	NULL
pp36-38	NULL
was	NULL
coprecipitated	NULL
with	NULL
Grb2	NULL
after	NULL
TCR	NULL
activation	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
39	NULL
,	NULL
41	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
clones	NULL
overexpressing	NULL
the	NULL
ZAP-70FF	NULL
mutant	NULL
(	NULL
FF18-22	NULL
and	NULL
FF18-21	NULL
)	NULL
,	NULL
a	NULL
marked	NULL
inhibition	NULL
of	NULL
tyrosine	NULL
-phosphorylated	NULL
pp36-38	NULL
associated	NULL
with	NULL
Grb2	NULL
was	NULL
observed	NULL
.	NULL

A	NULL
strong	NULL
decrease	NULL
of	NULL
an	NULL
unidentified	NULL
60-kDa	NULL
phosphoprotein	NULL
coprecipitating	NULL
with	NULL
Grb2	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
.	NULL

Anti-Grb2	NULL
immunoblots	NULL
32649	NULL
IP	NULL
:	NULL
anti-10	NULL
5.2	NULL
FFI8-22	NULL
anti-TCR	NULL
:	NULL
-	NULL
4+	NULL
-	NULL
+	NULL
-97	NULL
ZAP-70	NULL
FF	NULL
\	NULL
@	NULL
___	NULL
_	NULL
s	NULL
CW	NULL
_	NULL
ig	NULL
ZAP-70end	NULL
7	NULL
+-	NULL
#	NULL
80	NULL
-5	NULL
phospho-L	NULL
[	NULL
g	NULL
”	NULL
-215	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
ZAP-70FF	NULL
mutant	NULL
and	NULL
its	NULL
association	NULL
with	NULL
TCR	NULL
{	NULL
before	NULL
and	NULL
after	NULL
TCR	NULL
stimulation	NULL
.	NULL

FF18-22	NULL
and	NULL
JO	NULL
5.2	NULL
Jurkat	NULL
transfectants	NULL
(	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
for	NULL
3	NULL
min	NULL
and	NULL
lysed	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40-containing	NULL
buffer	NULL
.	NULL

Anti-	NULL
{	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
12	NULL
%	NULL
polyacrylamide	NULL
SDS-gel	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-phosphotyrosine	NULL
mAb	NULL
4G10	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
(	NULL
kDa	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Positions	NULL
of	NULL
endogenous	NULL
wild-type	NULL
ZAP-70	NULL
and	NULL
ZAP-70FF	NULL
,	NULL
respectively	NULL
,	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Ig	NULL
,	NULL
im-munoglobulin	NULL
heavy	NULL
chains	NULL
of	NULL
the	NULL
immunoprecipitating	NULL
antibody	NULL
;	NULL
IP	NULL
,	NULL
immunoprecipitation	NULL
.	NULL

»	NULL
&	NULL
&	NULL
&	NULL
§	NULL
97	NULL
69	NULL
-	NULL
eae	NULL
<	NULL
-	NULL
ZAP-70	NULL
tag	NULL
55	NULL
--	NULL
-	NULL
%	NULL
<	NULL
-	NULL
band	NULL
3	NULL
36.5	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

ZAP-70FF	NULL
mutant	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
has	NULL
an	NULL
increased	NULL
basal	NULL
kinase	NULL
activity	NULL
.	NULL

5	NULL
X	NULL
10°	NULL
cells	NULL
from	NULL
the	NULL
transfectants	NULL
WT15.8	NULL
,	NULL
FF18-22	NULL
,	NULL
and	NULL
KD12	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40-containing	NULL
buffer	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
anti-VSV-G-tag	NULL
antiserum	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
subjected	NULL
to	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
°°P	NULL
]	NULL
ATP	NULL
using	NULL
1	NULL
ug	NULL
of	NULL
band	NULL
3	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
12	NULL
%	NULL
polyacrylamide	NULL
SDS-gel	NULL
.	NULL

Gels	NULL
were	NULL
treated	NULL
with	NULL
KOH	NULL
and	NULL
dried	NULL
,	NULL
and	NULL
quantitation	NULL
of	NULL
band	NULL
3	NULL
phosphorylation	NULL
was	NULL
performed	NULL
by	NULL
PhosphorImager	NULL
scanning	NULL
followed	NULL
by	NULL
analysis	NULL
with	NULL
Image	NULL
Quant	NULL
software	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
(	NULL
in	NULL
thousands	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Under	NULL
the	NULL
assay	NULL
conditions	NULL
used	NULL
,	NULL
p56	NULL
``	NULL
**	NULL
kinase	NULL
activity	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

on	NULL
the	NULL
immunoprecipitates	NULL
showed	NULL
similar	NULL
amounts	NULL
of	NULL
Grb2	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
a	NULL
more	NULL
distal	NULL
event	NULL
in	NULL
the	NULL
Ras	NULL
pathway	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
ERKs	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
,	NULL
was	NULL
also	NULL
affected	NULL
by	NULL
the	NULL
overexpressed	NULL
ZAP-70FF	NULL
mutant	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
ERK-1	NULL
(	NULL
44	NULL
kDa	NULL
)	NULL
and	NULL
ERK-2	NULL
(	NULL
42	NULL
kDa	NULL
)	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
,	NULL
an	NULL
alteration	NULL
associated	NULL
to	NULL
their	NULL
activation	NULL
,	NULL
was	NULL
inhibited	NULL
after	NULL
TCR	NULL
stimulation	NULL
in	NULL
FF18-22	NULL
and	NULL
FF18-21	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

8C	NULL
shows	NULL
that	NULL
the	NULL
mobility	NULL
shift	NULL
of	NULL
both	NULL
ERKs	NULL
was	NULL
considerably	NULL
reduced	NULL
in	NULL
these	NULL
cells	NULL
lines	NULL
but	NULL
was	NULL
clearly	NULL
detectable	NULL
in	NULL
JO	NULL
5.2	NULL
control	NULL
cells	NULL
.	NULL

The	NULL
visibility	NULL
of	NULL
the	NULL
mobility	NULL
change	NULL
of	NULL
the	NULL
42-kDa	NULL
molecular	NULL
species	NULL
representing	NULL
ERK-2	NULL
is	NULL
partially	NULL
hindered	NULL
by	NULL
the	NULL
unshifted	NULL
44-kDa	NULL
ERK-1	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
dominant-negative	NULL
ZAP-70	NULL
mutated	NULL
in	NULL
the	NULL
regulatory	NULL
loop	NULL
of	NULL
the	NULL
kinase	NULL
domain	NULL
affects	NULL
both	NULL
the	NULL
SH2-mediated	NULL
association	NULL
of	NULL
pp36-38	NULL
with	NULL
Grb2	NULL
and	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
ERKs	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
overexpression	NULL
of	NULL
ZAP-70	NULL
mutated	NULL
on	NULL
both	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
inhibited	NULL
TCR-mediated	NULL
signaling	NULL
pathways	NULL
controlling	NULL
tran	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
32650	NULL
A	NULL
ZAP-70	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Activation	NULL
B	NULL
IP	NULL
:	NULL
anti-p56	NULL
!	NULL

¢	NULL
Total	NULL
cell	NULL
lysate	NULL
MBP-SH2	NULL
J0	NULL
5.2	NULL
FF18-22	NULL
105.2	NULL
FFI822	NULL
JO	NULL
5.2	NULL
FF18-22	NULL
anti-TCR	NULL
:	NULL
-	NULL
+	NULL
-o	NULL
+	NULL
+	NULL
%	NULL
+	NULL
R	NULL
4	NULL
a-	NULL
Tip	NULL
ZAP-70	NULL
FF	NULL
©	NULL
tuk	NULL
Wliil®	NULL
.	NULL

__	NULL
Go	NULL
__	NULL
ZAP-70end	NULL
*	NULL
--	NULL
wi	NULL
69	NULL
Blot	NULL
:	NULL
anti-tag	NULL
ps6	NULL
[	NULL
'	NULL
i	NULL
..	NULL
oe	NULL
-	NULL
@	NULL
Ig	NULL
Blot	NULL
:	NULL
anti-PTyr	NULL
Blot	NULL
:	NULL
anti-p56	NULL
!	NULL

¢k	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

ZAP-70FF	NULL
mutant	NULL
can	NULL
associate	NULL
with	NULL
p56	NULL
``	NULL
*	NULL
.	NULL

JO	NULL
5.2	NULL
and	NULL
FF18-22	NULL
transfectants	NULL
(	NULL
8	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
for	NULL
2	NULL
min	NULL
(	NULL
+	NULL
)	NULL
.	NULL

A	NULL
,	NULL
left	NULL
panel	NULL
:	NULL
after	NULL
solubilization	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40-containing	NULL
buffer	NULL
,	NULL
p56**	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
8	NULL
%	NULL
polyacrylamide	NULL
SDS-gel	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
using	NULL
anti-phosphotyrosine	NULL
mAb	NULL
4G10	NULL
.	NULL

A	NULL
,	NULL
right	NULL
panel	NULL
:	NULL
1/50	NULL
of	NULL
the	NULL
total	NULL
cell	NULL
lysates	NULL
prepared	NULL
from	NULL
stimulated	NULL
cells	NULL
(	NULL
+	NULL
)	NULL
was	NULL
loaded	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
and	NULL
analyzed	NULL
by	NULL
anti-p5	NULL
6	NULL
``	NULL
**	NULL
immunoblotting	NULL
.	NULL

B	NULL
,	NULL
Nonidet	NULL
P-40	NULL
lysates	NULL
from	NULL
JO	NULL
5.2	NULL
and	NULL
FF18-22	NULL
cells	NULL
(	NULL
10°	NULL
)	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
as	NULL
above	NULL
were	NULL
incubated	NULL
with	NULL
maltose-binding	NULL
protein-p56**SH2	NULL
covalently	NULL
coupled	NULL
to	NULL
Sepharose	NULL
beads	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
7	NULL
%	NULL
polyacrylamide	NULL
SDS-gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-tag	NULL
antiserum	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
in	NULL
thousands	NULL
.	NULL

A	NULL
IP	NULL
:	NULL
anti-Grb2	NULL
e	NULL
ka	NULL
&	NULL
'	NULL
&	NULL
``	NULL
&	NULL
(	NULL
8x	NULL
«	NULL
ﬁx	NULL
s	NULL
+00	NULL
-	NULL
+	NULL
-	NULL
o+	NULL
69	NULL
,	NULL
hs	NULL
I	NULL
lis/f-n.-i-—-	NULL
Blot	NULL
:	NULL
$	NULL
anti-PTyr	NULL
dik	NULL
i	NULL
wal	NULL
<	NULL
-pp36-38	NULL
Blot	NULL
:	NULL
Grh2	NULL
-	NULL
can	NULL
cus	NULL
a	NULL
»	NULL
cus	NULL
cm	NULL
»	NULL
can	NULL
ant	NULL
i-Grb2	NULL
B	NULL
A	NULL
v	NULL
v	NULL
I+	NULL
T	NULL
&	NULL
'	NULL
6	NULL
&	NULL
a	NULL
A	NULL
+	NULL
+	NULL
+	NULL
®	NULL
ERK-1	NULL
ERK-2	NULL
me	NULL
w	NULL
Yer	NULL
<	NULL
ee	NULL
-	NULL
.	NULL

®ERK2	NULL
>	NULL
_	NULL
==	NULL
as	NULL
&	NULL
as	NULL
==	NULL
``	NULL
~ERkq	NULL
Blot	NULL
:	NULL
-	NULL
anti-ERK	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Inhibition	NULL
of	NULL
pp36-38	NULL
association	NULL
to	NULL
Grb2	NULL
and	NULL
ERKs	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
in	NULL
cells	NULL
overexpressing	NULL
ZAP-70FF	NULL
.	NULL

A	NULL
,	NULL
upper	NULL
panel	NULL
:	NULL
the	NULL
indicated	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
2	NULL
min	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
(	NULL
+	NULL
)	NULL
.	NULL

Nonidet	NULL
P-40	NULL
cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-Grb2	NULL
antibody	NULL
,	NULL
and	NULL
immunocomplexes	NULL
were	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide	NULL
SDS-gel	NULL
and	NULL
analyzed	NULL
by	NULL
anti-phosphotyrosine	NULL
mAb	NULL
4G10	NULL
immunoblotting	NULL
.	NULL

Positions	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
and	NULL
immunoprecipitating	NULL
antibodies	NULL
(	NULL
Ig	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

A	NULL
,	NULL
lower	NULL
panel	NULL
:	NULL
the	NULL
same	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
the	NULL
anti-Grb2	NULL
antibody	NULL
.	NULL

B	NULL
,	NULL
equal	NULL
amount	NULL
of	NULL
proteins	NULL
(	NULL
determined	NULL
by	NULL
Bradford	NULL
assay	NULL
)	NULL
from	NULL
total	NULL
cell	NULL
lysates	NULL
from	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
anti-TCR-stimulated	NULL
cells	NULL
(	NULL
+	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
12.5	NULL
%	NULL
polyacrylamide	NULL
SDS-gels	NULL
(	NULL
acrylamide	NULL
:	NULL
bis-acrylamide	NULL
ratio	NULL
,	NULL
149:1	NULL
)	NULL
and	NULL
then	NULL
immunoblotted	NULL
using	NULL
anti-ERK	NULL
antibody	NULL
.	NULL

Position	NULL
of	NULL
unphospho-rylated	NULL
and	NULL
phosphorylated	NULL
forms	NULL
of	NULL
ERK-1	NULL
and	NULL
ERK-2	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
and	NULL
on	NULL
the	NULL
left	NULL
,	NULL
respectively	NULL
.	NULL

scriptional	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
ZAP-T70FF	NULL
reduced	NULL
NFAT	NULL
activation	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
and	NULL
that	NULL
this	NULL
block	NULL
was	NULL
proximal	NULL
in	NULL
the	NULL
TCR	NULL
signaling	NULL
cascade	NULL
because	NULL
it	NULL
can	NULL
be	NULL
bypassed	NULL
with	NULL
PMA	NULL
plus	NULL
calcium	NULL
ionophore	NULL
.	NULL

Because	NULL
an	NULL
excess	NULL
of	NULL
wild-type	NULL
ZAP-70	NULL
reversed	NULL
the	NULL
inhibitory	NULL
effect	NULL
on	NULL
NFAT	NULL
activation	NULL
(	NULL
this	NULL
was	NULL
also	NULL
true	NULL
when	NULL
the	NULL
ZAP-7O0FF	NULL
construct	NULL
was	NULL
transiently	NULL
cotransfected	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
wild-type	NULL
ZAP-70	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
ZAP-70FF	NULL
mutant	NULL
exerted	NULL
this	NULL
inhibition	NULL
beyond	NULL
the	NULL
signaling	NULL
steps	NULL
nor	NULL
mally	NULL
controlled	NULL
by	NULL
ZAP-70	NULL
.	NULL

Binding	NULL
to	NULL
ITAM	NULL
and	NULL
subsequent	NULL
phosphorylation/activation	NULL
of	NULL
ZAP-70	NULL
appear	NULL
to	NULL
be	NULL
obligatory	NULL
events	NULL
for	NULL
TCR-mediated	NULL
NFAT	NULL
activation	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
ZAP-70FF	NULL
might	NULL
primarily	NULL
interfere	NULL
at	NULL
this	NULL
level	NULL
.	NULL

Using	NULL
stable	NULL
transfectants	NULL
expressing	NULL
different	NULL
amounts	NULL
of	NULL
ZAP-70FF	NULL
,	NULL
it	NULL
was	NULL
evident	NULL
that	NULL
NFAT	NULL
inhibition	NULL
directly	NULL
correlated	NULL
with	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
mutant	NULL
bound	NULL
to	NULL
the	NULL
TCR	NULL
£	NULL
chain	NULL
.	NULL

However	NULL
,	NULL
even	NULL
in	NULL
cells	NULL
with	NULL
the	NULL
highest	NULL
levels	NULL
of	NULL
ZAP-7ZO0FF	NULL
,	NULL
tyrosine-phosphorylated	NULL
endogenous	NULL
ZAP-70	NULL
bound	NULL
to	NULL
the	NULL
£	NULL
chain	NULL
could	NULL
be	NULL
detected	NULL
after	NULL
TCR	NULL
stimulation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
substantial	NULL
inhibitory	NULL
effect	NULL
by	NULL
ZAP-70FF	NULL
might	NULL
not	NULL
be	NULL
simply	NULL
due	NULL
to	NULL
competition	NULL
for	NULL
ITAM	NULL
binding	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
an	NULL
excess	NULL
of	NULL
mutant	NULL
provoked	NULL
an	NULL
encumbrance	NULL
on	NULL
the	NULL
ITAMs	NULL
such	NULL
that	NULL
either	NULL
adequate	NULL
phosphorylation/activation	NULL
of	NULL
,	NULL
or	NULL
access	NULL
to	NULL
substrates	NULL
by	NULL
endogenous	NULL
ZAP-70	NULL
or	NULL
both	NULL
events	NULL
were	NULL
affected	NULL
.	NULL

Alternatively	NULL
,	NULL
ZAP-7OFF	NULL
could	NULL
impede	NULL
the	NULL
association	NULL
to	NULL
{	NULL
ITAM	NULL
of	NULL
other	NULL
signaling	NULL
components	NULL
,	NULL
such	NULL
as	NULL
the	NULL
She	NULL
adapter	NULL
protein	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
with	NULL
low	NULL
affinity	NULL
to	NULL
phosphorylated	NULL
£	NULL
ITAM	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
and	NULL
suggested	NULL
to	NULL
be	NULL
a	NULL
possible	NULL
connection	NULL
between	NULL
the	NULL
TCR	NULL
and	NULL
the	NULL
Ras	NULL
pathway	NULL
.	NULL

If	NULL
this	NULL
had	NULL
been	NULL
true	NULL
,	NULL
we	NULL
should	NULL
have	NULL
observed	NULL
an	NULL
inhibition	NULL
of	NULL
NFAT	NULL
activation	NULL
also	NULL
when	NULL
wild-type	NULL
ZAP-70	NULL
was	NULL
overexpressed	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
this	NULL
was	NULL
not	NULL
the	NULL
case	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
evidence	NULL
presented	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
the	NULL
ZAP-70FF	NULL
mutant	NULL
interfered	NULL
specifically	NULL
in	NULL
a	NULL
dominant-negative	NULL
fashion	NULL
with	NULL
the	NULL
normal	NULL
function	NULL
of	NULL
ZAP-70	NULL
.	NULL

Formation	NULL
of	NULL
an	NULL
active	NULL
NFAT	NULL
requires	NULL
both	NULL
calcium-regu-lated	NULL
calcineurin	NULL
and	NULL
Ras-regulated	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
pathways	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
indicated	NULL
that	NULL
ZAP-70FF	NULL
overexpression	NULL
negatively	NULL
affected	NULL
both	NULL
pathways	NULL
because	NULL
it	NULL
reduced	NULL
TCR-mediated	NULL
intracellular	NULL
calcium	NULL
concentration	NULL
increase	NULL
and	NULL
ERK	NULL
protein	NULL
mobility	NULL
shift	NULL
.	NULL

Upon	NULL
TCR	NULL
stimulation	NULL
,	NULL
pp36-38	NULL
,	NULL
probably	NULL
the	NULL
Link	NULL
protein	NULL
whose	NULL
gene	NULL
has	NULL
been	NULL
recently	NULL
cloned	NULL
(	NULL
48	NULL
)	NULL
,	NULL
binds	NULL
to	NULL
Grb2	NULL
and	NULL
phospholipase	NULL
Cyl	NULL
and	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
connecting	NULL
TCR-regu-lated	NULL
PTKs	NULL
to	NULL
the	NULL
Ras	NULL
pathway	NULL
and	NULL
phospholipase	NULL
Cy1	NULL
activation	NULL
(	NULL
39	NULL
,	NULL
41	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Reduced	NULL
levels	NULL
of	NULL
tyrosine-phosphorylated	NULL
pp36-38	NULL
bound	NULL
to	NULL
Grb2	NULL
were	NULL
observed	NULL
in	NULL
Jurkat	NULL
cell	NULL
transfectants	NULL
overexpressing	NULL
ZAP-70FF	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
our	NULL
data	NULL
,	NULL
overexpression	NULL
of	NULL
the	NULL
ZAP-70	NULL
SH2	NULL
domains	NULL
alone	NULL
(	NULL
SH2	NULL
N+C	NULL
)	NULL
,	NULL
which	NULL
inhibited	NULL
TCR-induced	NULL
NFAT	NULL
activation	NULL
,	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
provoke	NULL
a	NULL
similar	NULL
effect	NULL
on	NULL
pp36-38	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Our	NULL
preliminary	NULL
results	NULL
indicate	NULL
that	NULL
lower	NULL
amounts	NULL
of	NULL
tyrosine-phosphorylated	NULL
pp36-38	NULL
were	NULL
associated	NULL
with	NULL
phospholipase	NULL
Cy1	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
ZAP-7OFF	NULL
overexpression	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
both	NULL
calcium	NULL
increase	NULL
and	NULL
ERK	NULL
activation	NULL
by	NULL
the	NULL
ZAP-70	NULL
mutant	NULL
might	NULL
be	NULL
the	NULL
conse-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
ZAP-70	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Activation	NULL
quence	NULL
of	NULL
diminished	NULL
phosphorylation	NULL
of	NULL
pp36-38	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
data	NULL
suggest	NULL
that	NULL
ERK	NULL
activation	NULL
may	NULL
not	NULL
necessarily	NULL
be	NULL
related	NULL
to	NULL
phosphorylation	NULL
of	NULL
pp36-38	NULL
(	NULL
49	NULL
)	NULL
.	NULL

In	NULL
any	NULL
event	NULL
,	NULL
the	NULL
present	NULL
as	NULL
well	NULL
as	NULL
previous	NULL
results	NULL
(	NULL
50	NULL
)	NULL
suggest	NULL
that	NULL
ZAP-70	NULL
may	NULL
contribute	NULL
to	NULL
phosphorylation	NULL
of	NULL
pp36-38	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
have	NULL
suggested	NULL
that	NULL
p5	NULL
may	NULL
have	NULL
a	NULL
regulatory	NULL
role	NULL
on	NULL
ZAP-70	NULL
by	NULL
phosphorylating	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
implied	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
these	NULL
two	NULL
PTKs	NULL
is	NULL
required	NULL
for	NULL
effective	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
51	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
reported	NULL
that	NULL
p56kk	NULL
associates	NULL
via	NULL
its	NULL
SH2	NULL
domain	NULL
to	NULL
tyrosine-phosphorylated	NULL
ZAP-70	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
this	NULL
physical	NULL
interaction	NULL
are	NULL
not	NULL
yet	NULL
known	NULL
,	NULL
important	NULL
effects	NULL
in	NULL
TCR	NULL
signaling	NULL
may	NULL
be	NULL
hypothesized	NULL
,	NULL
such	NULL
as	NULL
p56	NULL
``	NULL
*-mediated	NULL
ZAP-70	NULL
phosphorylation	NULL
on	NULL
regulatory	NULL
tyrosines	NULL
and/or	NULL
p56	NULL
``	NULL
**	NULL
colocalization	NULL
with	NULL
the	NULL
activated	NULL
TCR	NULL
,	NULL
an	NULL
event	NULL
that	NULL
could	NULL
facilitate	NULL
phosphorylation	NULL
of	NULL
additional	NULL
substrates	NULL
.	NULL

The	NULL
association	NULL
of	NULL
these	NULL
two	NULL
PTKs	NULL
is	NULL
most	NULL
reminiscent	NULL
of	NULL
the	NULL
SH2-mediated	NULL
interaction	NULL
of	NULL
Sre	NULL
kinases	NULL
with	NULL
focal	NULL
adhesion	NULL
kinase	NULL
,	NULL
implicated	NULL
in	NULL
integrin-mediated	NULL
signal	NULL
transduction	NULL
(	NULL
53	NULL
)	NULL
or	NULL
with	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
and	NULL
colony-stimulating	NULL
fac-tor-1	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
(	NULL
54	NULL
,	NULL
55	NULL
)	NULL
.	NULL

In	NULL
all	NULL
three	NULL
cases	NULL
,	NULL
the	NULL
relevant	NULL
tyrosine-containing	NULL
motif	NULL
has	NULL
been	NULL
mapped	NULL
outside	NULL
of	NULL
the	NULL
kinase	NULL
domain	NULL
.	NULL

TCR	NULL
Z-associated	NULL
ZAP-7O0FF	NULL
was	NULL
phosphorylated	NULL
on	NULL
tyrosines	NULL
other	NULL
than	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
is	NULL
still	NULL
unclear	NULL
(	NULL
discussed	NULL
below	NULL
)	NULL
,	NULL
and	NULL
this	NULL
resulted	NULL
in	NULL
its	NULL
efficient	NULL
in	NULL
vitro	NULL
binding	NULL
to	NULL
the	NULL
p56	NULL
``	NULL
**	NULL
SH2	NULL
domain	NULL
and	NULL
association	NULL
with	NULL
p56	NULL
``	NULL
in	NULL
vivo	NULL
.	NULL

These	NULL
data	NULL
formally	NULL
rule	NULL
out	NULL
that	NULL
these	NULL
two	NULL
tyrosines	NULL
of	NULL
ZAP-70	NULL
mediate	NULL
the	NULL
association	NULL
with	NULL
p56	NULL
``	NULL
**	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
focal	NULL
adhesion	NULL
kinase	NULL
,	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
Tyr-397	NULL
,	NULL
responsible	NULL
for	NULL
the	NULL
SH2-mediated	NULL
Sre	NULL
kinase	NULL
binding	NULL
,	NULL
is	NULL
the	NULL
major	NULL
autophosphorylation	NULL
site	NULL
(	NULL
53	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
phosphorylation	NULL
of	NULL
Tyr-576	NULL
and	NULL
Tyr-577	NULL
,	NULL
in	NULL
the	NULL
putative	NULL
activation	NULL
loop	NULL
of	NULL
focal	NULL
adhesion	NULL
kinase	NULL
domain	NULL
,	NULL
as	NULL
well	NULL
as	NULL
two	NULL
other	NULL
tyrosines	NULL
,	NULL
is	NULL
essentially	NULL
mediated	NULL
by	NULL
Sre	NULL
PTKs	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
mutation	NULL
of	NULL
Tyr-397	NULL
dramatically	NULL
reduced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
focal	NULL
adhesion	NULL
kinase	NULL
and	NULL
its	NULL
in	NULL
vitro	NULL
kinase	NULL
activity	NULL
(	NULL
56	NULL
)	NULL
.	NULL

It	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
an	NULL
analogous	NULL
scheme	NULL
applies	NULL
to	NULL
ZAP-70	NULL
.	NULL

Once	NULL
recruited	NULL
to	NULL
the	NULL
ITAMs	NULL
,	NULL
ZAP-70	NULL
,	NULL
which	NULL
possesses	NULL
a	NULL
basal	NULL
kinase	NULL
activity	NULL
(	NULL
Refs	NULL
.	NULL

14-16	NULL
and	NULL
the	NULL
present	NULL
study	NULL
)	NULL
may	NULL
undergo	NULL
autophosphorylation	NULL
(	NULL
24	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
p56	NULL
``	NULL
*	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
would	NULL
phosphorylate	NULL
ZAP-70	NULL
on	NULL
Tyr-492	NULL
and/or	NULL
Tyr-493	NULL
(	NULL
and	NULL
perhaps	NULL
on	NULL
other	NULL
tyrosines	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
up-regulation	NULL
of	NULL
ZAP-70	NULL
kinase	NULL
activity	NULL
and	NULL
efficient	NULL
phosphorylation	NULL
of	NULL
its	NULL
substrates	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
this	NULL
model	NULL
,	NULL
p56'*	NULL
``	NULL
*	NULL
,	NULL
carrying	NULL
a	NULL
point	NULL
mutation	NULL
that	NULL
abolished	NULL
binding	NULL
of	NULL
its	NULL
SH2	NULL
domain	NULL
to	NULL
phosphotyrosine	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
unable	NULL
to	NULL
reconstitute	NULL
TCR-induced	NULL
NFAT	NULL
activation	NULL
in	NULL
a	NULL
p56	NULL
``	NULL
*-null	NULL
Jurkat	NULL
cell	NULL
line	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
p56	NULL
``	NULL
**	NULL
recruited	NULL
by	NULL
ZAP-70	NULL
may	NULL
not	NULL
be	NULL
directly	NULL
implicated	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
calcineurin	NULL
and	NULL
Ras	NULL
pathways	NULL
.	NULL

However	NULL
,	NULL
because	NULL
our	NULL
observations	NULL
were	NULL
restricted	NULL
to	NULL
TCR-mediated	NULL
NFAT	NULL
activation	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
,	NULL
p56	NULL
``	NULL
**	NULL
controls	NULL
key	NULL
events	NULL
of	NULL
those	NULL
pathways	NULL
mediated	NULL
through	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
the	NULL
CD4/CD8	NULL
co-receptors	NULL
(	NULL
57	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
recently	NULL
that	NULL
overexpression	NULL
of	NULL
ZAP-70	NULL
SH2	NULL
(	NULL
N+C	NULL
)	NULL
domains	NULL
alone	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
resulted	NULL
in	NULL
increased	NULL
basal	NULL
levels	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
£	NULL
(	NULL
50	NULL
)	NULL
and	NULL
that	NULL
a	NULL
kinase	NULL
domain-deleted	NULL
Syk	NULL
mutant	NULL
provoked	NULL
the	NULL
same	NULL
effect	NULL
on	NULL
the	NULL
FceeRI	NULL
B	NULL
and	NULL
y	NULL
chains	NULL
in	NULL
unstimulated	NULL
RBL	NULL
cells	NULL
(	NULL
58	NULL
)	NULL
.	NULL

This	NULL
receptor	NULL
clustering-independent	NULL
ITAM	NULL
phosphorylation	NULL
was	NULL
also	NULL
observed	NULL
by	NULL
overexpressing	NULL
ZAP-7OFF	NULL
.	NULL

As	NULL
discussed	NULL
previously	NULL
(	NULL
58	NULL
)	NULL
,	NULL
this	NULL
effect	NULL
may	NULL
be	NULL
best	NULL
explained	NULL
by	NULL
assuming	NULL
that	NULL
an	NULL
ongoing	NULL
ITAM	NULL
phosphorylation	NULL
is	NULL
carried	NULL
out	NULL
under	NULL
basal	NULL
conditions	NULL
by	NULL
Sre	NULL
kinases	NULL
,	NULL
but	NULL
accu-	NULL
Glck	NULL
32651	NULL
mulation	NULL
of	NULL
phosphorylated	NULL
ITAMs	NULL
is	NULL
prevented	NULL
by	NULL
the	NULL
action	NULL
of	NULL
a	NULL
phosphatase	NULL
that	NULL
dephosphorylates	NULL
them	NULL
faster	NULL
than	NULL
they	NULL
are	NULL
phosphorylated	NULL
.	NULL

Thus	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
ZAP-70	NULL
mutant	NULL
or	NULL
wild	NULL
type	NULL
may	NULL
lead	NULL
to	NULL
the	NULL
protection	NULL
of	NULL
ITAM	NULL
tyrosine	NULL
residues	NULL
by	NULL
the	NULL
SH2	NULL
domains	NULL
and	NULL
accumulation	NULL
of	NULL
phosphorylated	NULL
ITAMs	NULL
.	NULL

Under	NULL
normal	NULL
circumstances	NULL
,	NULL
TCR	NULL
engagement	NULL
may	NULL
create	NULL
the	NULL
conditions	NULL
for	NULL
accelerating	NULL
ITAM	NULL
phosphorylation	NULL
or	NULL
reducing	NULL
their	NULL
dephosphorylation	NULL
(	NULL
e.g	NULL
.	NULL

by	NULL
sequestration	NULL
from	NULL
phosphata-ses	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
,	NULL
as	NULL
reported	NULL
here	NULL
,	NULL
wild-type	NULL
ZAP-70	NULL
transiently	NULL
overexpressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
NFAT	NULL
activation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCR	NULL
cross-linking	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
clustering	NULL
onto	NULL
the	NULL
ITAMs	NULL
and	NULL
subsequent	NULL
activation	NULL
of	NULL
ZAP-70	NULL
(	NULL
probably	NULL
by	NULL
p56	NULL
``	NULL
**	NULL
)	NULL
is	NULL
,	NULL
by	NULL
itself	NULL
,	NULL
not	NULL
only	NULL
necessary	NULL
but	NULL
also	NULL
sufficient	NULL
to	NULL
ignite	NULL
the	NULL
signaling	NULL
cascade	NULL
leading	NULL
to	NULL
calcium/calcineurin	NULL
and	NULL
Ras	NULL
pathway	NULL
activation	NULL
.	NULL

The	NULL
dominant-negative	NULL
effect	NULL
on	NULL
NFAT	NULL
activation	NULL
by	NULL
ZAP-70FF	NULL
was	NULL
of	NULL
similar	NULL
magnitude	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
ZAP-70	NULL
kinase-defective	NULL
mutant	NULL
,	NULL
yet	NULL
the	NULL
former	NULL
bound	NULL
to	NULL
TCR	NULL
£	NULL
was	NULL
found	NULL
to	NULL
be	NULL
effectively	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
.	NULL

Which	NULL
then	NULL
was	NULL
the	NULL
PTK	NULL
responsible	NULL
for	NULL
phosphorylating	NULL
ZAP-70FF	NULL
?	NULL

Others	NULL
have	NULL
reported	NULL
that	NULL
a	NULL
kinase-deleted	NULL
mutant	NULL
of	NULL
Syk	NULL
associated	NULL
to	NULL
/y	NULL
ITAM	NULL
of	NULL
the	NULL
FeeRI	NULL
receptor	NULL
in	NULL
RBL	NULL
cells	NULL
could	NULL
be	NULL
tyrosine-phosphorylated	NULL
when	NULL
overexpressed	NULL
(	NULL
58	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
obtained	NULL
similar	NULL
data	NULL
with	NULL
the	NULL
ZAP-70	NULL
kinase-defective	NULL
mutant	NULL
transiently	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
endogenous	NULL
ZAP-70	NULL
may	NULL
in	NULL
part	NULL
contribute	NULL
to	NULL
phosphorylate	NULL
the	NULL
expressed	NULL
mutants	NULL
and	NULL
,	NULL
by	NULL
the	NULL
mechanism	NULL
proposed	NULL
above	NULL
,	NULL
another	NULL
PTK	NULL
,	NULL
such	NULL
as	NULL
p56	NULL
``	NULL
**	NULL
,	NULL
may	NULL
further	NULL
mediate	NULL
this	NULL
event	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
ZAP-7OFF	NULL
mutant	NULL
,	NULL
there	NULL
was	NULL
an	NULL
additional	NULL
complication	NULL
because	NULL
its	NULL
in	NULL
vitro	NULL
kinase	NULL
activity	NULL
was	NULL
found	NULL
to	NULL
be	NULL
augmented	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
analyzing	NULL
Y492F	NULL
or	NULL
Y492F/Y493F	NULL
ZAP-70	NULL
mutants	NULL
expressed	NULL
in	NULL
Cos	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
it	NULL
was	NULL
speculated	NULL
that	NULL
these	NULL
tyrosines	NULL
have	NULL
distinct	NULL
roles	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
kinase	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
ZAP-70	NULL
mutated	NULL
on	NULL
both	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
was	NULL
able	NULL
to	NULL
(	NULL
trans	NULL
)	NULL
phosphorylate	NULL
itself	NULL
when	NULL
bound	NULL
to	NULL
the	NULL
ITAM	NULL
but	NULL
was	NULL
unable	NULL
to	NULL
phosphorylate	NULL
cellular	NULL
substrates	NULL
,	NULL
possibly	NULL
reflecting	NULL
a	NULL
fine	NULL
mechanism	NULL
of	NULL
kinase	NULL
activity	NULL
regulation	NULL
by	NULL
Tyr-492	NULL
and	NULL
Tyr-493	NULL
.	NULL

Perhaps	NULL
phosphorylation	NULL
of	NULL
Tyr-492	NULL
(	NULL
or	NULL
the	NULL
phenylanine	NULL
substitution	NULL
)	NULL
may	NULL
unlock	NULL
the	NULL
catalytic	NULL
site	NULL
,	NULL
thus	NULL
facilitating	NULL
the	NULL
autophosphorylation	NULL
step	NULL
,	NULL
whereas	NULL
phosphorylation	NULL
of	NULL
Tyr-493	NULL
may	NULL
be	NULL
essential	NULL
for	NULL
stabilizing	NULL
the	NULL
kinase	NULL
activation	NULL
loop	NULL
(	NULL
21	NULL
)	NULL
important	NULL
for	NULL
full	NULL
accessibility	NULL
to	NULL
more	NULL
distal	NULL
and/or	NULL
less	NULL
available	NULL
cellular	NULL
substrates	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Drs	NULL
.	NULL

A.	NULL
Weiss	NULL
,	NULL
E.	NULL
L.	NULL
Reinherz	NULL
,	NULL
M.	NULL
Arpin	NULL
,	NULL
C.	NULL
T.	NULL
Baldari	NULL
,	NULL
J.	NULL
Ravetch	NULL
,	NULL
R.	NULL
Sekaly	NULL
,	NULL
F.	NULL
Denis	NULL
,	NULL
and	NULL
R.	NULL
Wange	NULL
for	NULL
providing	NULL
reagents	NULL
,	NULL
cDNAs	NULL
,	NULL
and	NULL
expression	NULL
vectors	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Drs	NULL
.	NULL

A.	NULL
Alcover	NULL
,	NULL
S.	NULL
Pellegrini	NULL
,	NULL
R.	NULL
Weil	NULL
,	NULL
and	NULL
G.	NULL
Langsley	NULL
for	NULL
reading	NULL
the	NULL
manuscript	NULL
and	NULL
for	NULL
suggestions	NULL
and	NULL
W.	NULL
Houssin	NULL
for	NULL
excellent	NULL
secretarial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Littman	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
263-274	NULL
.	NULL

Baniyash	NULL
,	NULL
M.	NULL
,	NULL
Garcia-Morales	NULL
,	NULL
P.	NULL
,	NULL
Luong	NULL
,	NULL
E.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
18225-18230	NULL
3	NULL
.	NULL

Qian	NULL
,	NULL
D.	NULL
,	NULL
Griswold-Prenner	NULL
,	NULL
I.	NULL
,	NULL
Rosner	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
and	NULL
Fitch	NULL
,	NULL
F.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
4488-4493	NULL
4	NULL
.	NULL

Frank	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Cenciarelli	NULL
,	NULL
C.	NULL
,	NULL
Niklinska	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Letourneur	NULL
,	NULL
F.	NULL
,	NULL
Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
13656-13660	NULL
5	NULL
.	NULL

Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177	NULL
,	NULL
1098-1103	NULL
6	NULL
.	NULL

Straus	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
585-598	NULL
7	NULL
.	NULL

Karnitz	NULL
,	NULL
L.	NULL
,	NULL
Sutor	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Torigoe	NULL
,	NULL
T.	NULL
,	NULL
Reed	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Bell	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
McKean	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Leibson	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Abraham	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4521-4530	NULL
8	NULL
.	NULL

Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
van	NULL
Oers	NULL
,	NULL
N.	NULL
S.	NULL
C.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
1186-1139	NULL
9	NULL
.	NULL

Hall	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Sancho	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Terhorst	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
915-918	NULL
10.	NULL
van	NULL
Oers	NULL
,	NULL
N.	NULL
S.	NULL
C.	NULL
,	NULL
Killeen	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
1053-1062	NULL
11	NULL
.	NULL

Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Turck	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
649-662	NULL
12	NULL
.	NULL

Wange	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Malek	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Desiderio	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
19797-19801	NULL
13	NULL
.	NULL

Koyasu	NULL
,	NULL
S.	NULL
,	NULL
Tse	NULL
,	NULL
A.	NULL
G.	NULL
D.	NULL
,	NULL
Moingeon	NULL
,	NULL
P.	NULL
,	NULL
Hussey	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Mildonian	NULL
,	NULL
A.	NULL
,	NULL
Hanni-	NULL
lled	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
32652	NULL
14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

82	NULL
.	NULL

38	NULL
.	NULL

84	NULL
.	NULL

35.	NULL
sian	NULL
,	NULL
J.	NULL
,	NULL
Clayton	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
and	NULL
Reinherz	NULL
,	NULL
E.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
6693-6697	NULL
Wange	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Guitian	NULL
,	NULL
R.	NULL
,	NULL
Isakov	NULL
,	NULL
N.	NULL
,	NULL
Watts	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Aebersold	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
18730-18733	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Dalton	NULL
,	NULL
M.	NULL
,	NULL
Johnson	NULL
,	NULL
R.	NULL
,	NULL
Kong	NULL
,	NULL
G.-H.	NULL
,	NULL
Wang	NULL
,	NULL
T.	NULL
,	NULL
Thoma	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kurosaki	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
2499-2508	NULL
Burkhardt	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Stealey	NULL
,	NULL
B.	NULL
,	NULL
Rowley	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Mahajan	NULL
,	NULL
S.	NULL
,	NULL
Prendergast	NULL
,	NULL
M.	NULL
,	NULL
Fargnoli	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
23642-23647	NULL
Arpaia	NULL
,	NULL
E.	NULL
,	NULL
Shahar	NULL
,	NULL
M.	NULL
,	NULL
Dadi	NULL
,	NULL
H.	NULL
,	NULL
Cohen	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Roifman	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
947-958	NULL
Chan	NULL
,	NULL
A.	NULL
,	NULL
Kadlecek	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Elder	NULL
,	NULL
M.	NULL
,	NULL
Filipovich	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Kuo	NULL
,	NULL
W.-L.	NULL
,	NULL
Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Parslow	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
1599-1601	NULL
Watts	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Affolter	NULL
,	NULL
M.	NULL
,	NULL
Krebs	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Wange	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Aebersold	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
29520-29529	NULL
Hanks	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Hunter	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
in	NULL
The	NULL
Protein	NULL
Facts	NULL
Book	NULL
(	NULL
Hardie	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Hanks	NULL
,	NULL
S.	NULL
,	NULL
eds	NULL
)	NULL
Vol	NULL
.	NULL

1	NULL
,	NULL
pp	NULL
.	NULL

7-47	NULL
,	NULL
Academic	NULL
Press	NULL
,	NULL
London	NULL
Johnson	NULL
,	NULL
L.	NULL
N.	NULL
,	NULL
Noble	NULL
,	NULL
M.	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
149-158	NULL
Duplay	NULL
,	NULL
P.	NULL
,	NULL
Thome	NULL
,	NULL
M.	NULL
,	NULL
Herve	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Acuto	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
,	NULL
1163-1172	NULL
Thome	NULL
,	NULL
M.	NULL
,	NULL
Duplay	NULL
,	NULL
P.	NULL
,	NULL
Guttinger	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Acuto	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
1997-2006	NULL
Neumeister	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Zhu	NULL
,	NULL
Y.	NULL
,	NULL
Richard	NULL
,	NULL
S.	NULL
,	NULL
Terhorst	NULL
,	NULL
C.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Shaw	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
8171-3178	NULL
Kreis	NULL
,	NULL
T.	NULL
E.	NULL
(	NULL
1986	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

5	NULL
,	NULL
981-941	NULL
de	NULL
Martin	NULL
,	NULL
R.	NULL
,	NULL
Strasswimmer	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Philipson	NULL
,	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

124	NULL
,	NULL
137-138	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Higgins	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Lacy	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
1617-1619	NULL
Takebe	NULL
,	NULL
Y.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
Hoy	NULL
,	NULL
P.	NULL
,	NULL
Yokota	NULL
,	NULL
K.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
466-472	NULL
Kao	NULL
,	NULL
J.	NULL
P.	NULL
Y.	NULL
,	NULL
Harootunian	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
and	NULL
Tsien	NULL
,	NULL
R.	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
8179-8184	NULL
Lewis	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Calahan	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
Regul	NULL
.	NULL

1	NULL
,	NULL
99-112	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Belagaje	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
Tan	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Nocka	NULL
,	NULL
R.	NULL
,	NULL
Prabir	NULL
,	NULL
P.	NULL
,	NULL
Traktman	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Besmer	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
209	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Clipstone	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

68	NULL
,	NULL
1045-1083	NULL
Woodrow	NULL
,	NULL
M.	NULL
,	NULL
Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1517-1522	NULL
Thastrup	NULL
,	NULL
O.	NULL
,	NULL
Cullen	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Drobak	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Hanley	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Dawson	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
2466-2470	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
58	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

ZAP-70	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Activation	NULL
Lytton	NULL
,	NULL
J.	NULL
,	NULL
Westlin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hanley	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
17067-17071	NULL
Danielian	NULL
,	NULL
S.	NULL
,	NULL
Fagard	NULL
,	NULL
R.	NULL
,	NULL
Alcover	NULL
,	NULL
A.	NULL
,	NULL
Acuto	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Fischer	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

19	NULL
,	NULL
2183-2189	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

8	NULL
,	NULL
278-275	NULL
Buday	NULL
,	NULL
L.	NULL
,	NULL
Egan	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Viciana	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Downward	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
9019-9028	NULL
Reif	NULL
,	NULL
K.	NULL
,	NULL
Buday	NULL
,	NULL
L.	NULL
,	NULL
Downward	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
14081-14087	NULL
Sich	NULL
,	NULL
M.	NULL
,	NULL
Batzer	NULL
,	NULL
A.	NULL
,	NULL
Schlessinger	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
44835-4442	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Jackman	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Sun	NULL
,	NULL
Q.	NULL
,	NULL
Olson	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Findell	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
21608-21613	NULL
Meisner	NULL
,	NULL
H.	NULL
,	NULL
Conway	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Hartley	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Czech	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3571-3578	NULL
Leevers	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Marshall	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
569-574	NULL
Nel	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Hanekom	NULL
,	NULL
C.	NULL
,	NULL
Rheeder	NULL
,	NULL
A.	NULL
,	NULL
Williams	NULL
,	NULL
K.	NULL
,	NULL
Pollack	NULL
,	NULL
S.	NULL
,	NULL
Katz	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Landreth	NULL
,	NULL
G.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
2683-2689	NULL
Ravichandran	NULL
,	NULL
K.	NULL
,	NULL
Kay	NULL
Lee	NULL
,	NULL
K.	NULL
,	NULL
Songyang	NULL
,	NULL
Z.	NULL
,	NULL
Cantley	NULL
,	NULL
L.	NULL
,	NULL
Burn	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Burakoff	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
902-905	NULL
Osman	NULL
,	NULL
N.	NULL
,	NULL
Lucas	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Turner	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
13981-13986	NULL
Huang	NULL
,	NULL
X.	NULL
L.	NULL
,	NULL
Li	NULL
,	NULL
K.	NULL
,	NULL
Tanaka	NULL
,	NULL
K.	NULL
,	NULL
Moore	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hayashi	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
11618-11622	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Musci	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
2823-2829	NULL
Qian	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
Mollenauer	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
611-620	NULL
.	NULL

Kolanus	NULL
,	NULL
W.	NULL
,	NULL
Romeo	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Seed	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
74	NULL
,	NULL
171-183	NULL
52	NULL
.	NULL

Straus	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Patai	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
9976-9981	NULL
Shaller	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Hildebrand	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Shannon	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Fox	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Vines	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Parsons	NULL
,	NULL
J.	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1680-1688	NULL
Mori	NULL
,	NULL
S.	NULL
,	NULL
Rénnstrand	NULL
,	NULL
L.	NULL
,	NULL
Yokote	NULL
,	NULL
K.	NULL
,	NULL
Engstrom	NULL
,	NULL
A.	NULL
,	NULL
Courtneidge	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Claesson-Welsh	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Heldin	NULL
,	NULL
C.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2257-2264	NULL
Alonso	NULL
,	NULL
G.	NULL
,	NULL
Koeg	NULL
!	NULL

,	NULL
M.	NULL
,	NULL
Mazurenko	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Courtneidge	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
9840-9848	NULL
.	NULL

Calalb	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Polte	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Hanks	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
954-963	NULL
.	NULL

Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Pelicci	NULL
,	NULL
G.	NULL
,	NULL
Di	NULL
Somma	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Milia	NULL
,	NULL
E.	NULL
,	NULL
Giuli	NULL
,	NULL
S.	NULL
,	NULL
Pelicci	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
Telford	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
10	NULL
,	NULL
1141-1147	NULL
.	NULL

Scharenberg	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
Cuenod	NULL
,	NULL
B.	NULL
,	NULL
Yamamura	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
3385	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Mutation	NULL
of	NULL
Tyrosines	NULL
492/493	NULL
in	NULL
the	NULL
Kinase	NULL
Domain	NULL
of	NULL
ZAP-70	NULL
Affects	NULL
Multiple	NULL
T-cell	NULL
Receptor	NULL
Signaling	NULL
Pathways	NULL
Dominique	NULL
Mége	NULL
,	NULL
Vincenzo	NULL
Di	NULL
Bartolo	NULL
,	NULL
Valérie	NULL
Germain	NULL
,	NULL
Loretta	NULL
Tuosto	NULL
,	NULL
Fredérique	NULL
Michel	NULL
and	NULL
Oreste	NULL
Acuto	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:32644-32652.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.51.32644	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/51/32644	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
58	NULL
references	NULL
,	NULL
40	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

